Toxicology studies in Caenorhabditis elegans by Budd, Chloe Denisha
Budd, Chloe Denisha (2008) Toxicology studies in 
Caenorhabditis elegans. MRes thesis, University of 
Nottingham. 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/10613/1/ChloeBuddMResThesisNov2008.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
· Copyright and all moral rights to the version of the paper presented here belong to 
the individual author(s) and/or other copyright owners.
· To the extent reasonable and practicable the material made available in Nottingham 
ePrints has been checked for eligibility before being made available.
· Copies of full items can be used for personal research or study, educational, or not-
for-profit purposes without prior permission or charge provided that the authors, title 
and full bibliographic details are credited, a hyperlink and/or URL is given for the 
original metadata page and the content is not changed in any way.
· Quotations or similar reproductions must be sufficiently acknowledged.
Please see our full end user licence at: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf 
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
  
 
TOXICOLOGY STUDIES IN 
CAENORHABDITIS ELEGANS 
 
 
 
 
 
 
 
       By 
 
 
 
Chloe Denisha Budd, BSc (Hons). 
 
 
 
 
 
 
Thesis submitted to the University of Nottingham 
for the degree of Master of Research 
 
 
 
 
 
September 2008 
 
 
 
 Abstract 
The nematode Caenorhabditis elegans was established as a model organism to study in 
1965. In this study, C.elegans are used as a model system in which to examine the 
possible mechanisms of toxicity caused in humans by the anti-malarial drugs quinine and 
chloroquine, as well as toxicity caused in rodents by furan and investigating the 
pharmacology of the insecticides DDT and deltamethrin and how they affect 
invertebrates. 
Toxicity assays were used to determine what effects these 5 toxins have on C.elegans at 
different stages of its life cycle. The effects on growth, brood size and lethality were 
determined using three types of assays. These assays were robust, producing 
reproducible results and identifying specific toxicity. 
The results of these assays enabled the identification of a phenotype for each type of 
assay, and the inhibiting concentration (if any), for all the toxins tested. 
Quinine had a dose-dependent inhibitory effect on larval growth and brood size. 
Chloroquine, furan and DDT all had an inhibitory effect on growth, brood size and 
lethality of C.elegans. Chloroquine and DDT showed a greater potency on larval growth 
while furan showed a higher potency on brood size. Deltamethrin showed inhibitory 
effects on larval growth but showed no significant effect to the brood size and lethality 
of C.elegans. Deltamethrin shows stage-specific toxicity, as larval growth is significantly 
inhibited and effects on brood size and lethality are insignificant. 
The lat-1 (ok1465) C.elegans strain has a 2209bp deletion of the lat-1 gene, and 
approximately 97% of these worms die before adulthood, with only 2-3 adult offspring 
per animal. The lat-1 (ok1465) C.elegans was crossed with the CB4856 (Hawaiian) wild-
type C.elegans strain for 6 generations to produce a strain with the ok1465 allele in a 
Hawaiian C.elegans background. 
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 A mutagenesis could then be performed to screen and select for mutants that were 
resistant to the effects of the drug tested at concentrations that are toxic to wild-type 
animals. In the case of lat-1 (ok1465) C.elegans, screening would be to identify mutant 
individuals that no longer showed lethality; a resistant mutant would produce 300+ 
viable offspring. Gene mapping would then be used to identify these mutations. 
The hypothesis is that for the toxins tested, the mechanism by which they exert their 
toxic effects in C.elegans would be the same as for mammals and invertebrates. 
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1. Introduction 
 
1.1  Caenorhabditis elegans 
 
1.1.1 Caenorhabditis elegans as a model organism. 
C. elegans is a free living nematode, present in soil and found in temperate regions of the 
world. The C.elegans was selected by Dr. Sydney Brenner in 1965, as an experimental 
model organism to study animal development and behaviour (Riddle 1997). In the wild, 
C.elegans feed on the micro-organisms that develop on decaying vegetable matter. In the 
laboratory C.elegans are easily cultured on agar medium plates with Escherichia coli 
OP50 as a food source. The ease of laboratory cultivation, its small size, large brood 
size, short development time and well studied biology make the C.elegans an ideal 
model organism for biological studies. The transparency of the C.elegans allows for high 
quality microscopic images to be taken. 
 
1.1.2 Anatomy 
C.elegans is small with the adult hermaphrodite growing to a maximum length and 
diameter of approximately 1mm and 80µm respectively. An adult hermaphrodite has a 
total of 959 somatic cells and 1031 in males, of which 302 are nerve cells.  The 
C.elegans body consists of two concentric tubes which are separated by the 
pseudocoelom; a fluid filled space. Internal hydrostatic pressure maintains the C.elegans 
shape (Riddle 1997 & White 1988). A collagenous, extra-cellular cuticle, secreted by the 
underlying hypodermis covers the outer tube (Kramer 1997). Between each of the four 
larval molts the old cuticle is shed and a new stage specific cuticle is secreted. The body 
of the C.elegans has four strips of muscle along its length which is attached to the 
cuticle. Muscle contraction and relaxation causes movement of C.elegans in a sinusoidal 
movement in the dorsal-ventral plane, which can be observed on an agar plate (Mee 
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2002). C.elegans can move forward or backward in response to attractants or repellents 
in the environment (Riddle 1997). The water in the medium of agar plates creates surface 
tension which confines the C.elegans to the surface (Mee 2002). 
The nematode C.elegans can be found as either hermaphrodite or male, however in wild-
type N2 strain populations the majority of worms are hermaphrodite and males arise 
infrequently at a rate of 0.1%. The male C.elegans only produces sperm and must mate 
with a hermaphrodite to reproduce. The C.elegans hermaphrodite is self-fertilising, 
producing both sperm and oocytes. The sperm is produced in the spermatheca and the 
oocytes are produced in the gonads. A self-fertilised hermaphrodite produces 
approximately 300 hermaphrodite only offspring, however if mating with a male occurs 
the hermaphrodite can produce more than 1000 offspring. The offspring resulting from a 
mating will be 50% male and 50% hermaphrodite. Because of the very low occurrence 
of males in normal C.elegans populations, mating rarely occurs, and in the laboratory 
most C.elegans populations are generated by self-fertilisation. C.elegans hermaphrodites 
have 5 autosomes and two X chromosomes (XX), the male has one X chromosome 
designated as XO (Hodgkin 1979). Males occur spontaneously by means of 
nondisjunction in the germ line of hermaphrodites, causing the loss of an X chromosome 
to produce the XO male. 
Figure 1.3 below shows a diagram of the anatomy of an adult C.elegans hermaphrodite. 
The C.elegans is an unsegmented nematode with a cylindrical shape body that is tapered 
at the ends (wormatlas.org). The mouth is at the very tip of the head of the worm, 
followed by the pharynx which connects to the intestine and runs along the length of the 
body ending at the rectum. The male C.elegans is a similar size, although the male is a 
little shorter and thinner. They have a similar general anatomy to the hermaphrodite, but 
males C.elegans have a clearly visible fan shaped tail which is used for clasping the 
hermaphrodite during mating (Mee 2002). 
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Figure 1.1.2 Diagram showing the anatomy of an adult hermaphrodite C.elegans 
worm. (Taken from www.wormatlas.org) Basic C.elegans anatomy showing the mouth, 
pharynx, gut and gonads. 
 
 1.1.3   Life cycle 
The C.elegans has a short generation time, the entire complete life cycle from egg to egg 
producing hermaphrodite occurs over 3 days at 20°C under normal laboratory 
conditions. The length of the life cycle can vary with temperature, as C.elegans can grow 
over a range of temperatures, with the rate of growth increasing with temperature (Mee 
2002) C.elegans populations in the laboratory are typically grown between 15ºC and 
25°C. The length of the life cycle can vary between 6 days at 15ºC and 3 days at 25°C. 
Optimal growth occurs at 20ºC with approximately 300 offspring produced over 4 days, 
and a life span of 2-3 weeks. 
The C.elegans life cycle consists of an embryonic stage followed by four larval stages 
designated L1-L4 and a final adult stage. Each of the larval stages is marked with a molt 
where the old cuticle is shed and a new stage-specific cuticle is synthesised. 
(wormatlas.org) The C.elegans eggs are fertilised within the hermaphrodite and are laid 
at approximately the 30-cell stage. At 20°C embryonic development occurs over 14 
hours and postembryonic development occurs over 43 hours. Larval molts occur 
successively at the following hours following fertilisation: L1- L2 = 29 hours, L2-L3 = 
 12
38 hours, L3-L4 = 47 hours L4 -Adult = 57 hours. The C.elegans life cycle is 
summarised below in figure 1.1.3. 
 
 
 10 hours 
14 hours Up to 4 months 
9 hours 
 
 
13 hours 
9 hours 
15 hours 
 
Figure 1.1.3 Life cycle of C.elegans at 20ºC adapted from wormatlas.org. 
The numbers in blue show the length of time between each larval molt. The length of the 
C.elegans at each stage of development is shown in micrometers (µm) next to the stage 
name. 
 
The dauer stage is an alternative larval stage which occurs in crowded populations or in 
the absence of food. The dauer is formed at the second molt and are non-feeding and 
non-developing. Whereas wild-type C.elegans only have a life span of 2-3 weeks, under 
normal laboratory conditions, dauer larvae can survive for up to  3-4 months. In order to 
survive dauer larvae alter their energy metabolism and accumulate fat in the hypodermal 
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and intestinal cells. Dauer larvae are thin and have plugged mouths such that they cannot 
eat; they remain motionless most of the time unless touched when they can move faster 
than L3 larvae, which is thought to be a survival technique. Normal development is 
resumed when dauer larvae encounter food (Mee et al 2002). 
 
1.2 Quinine 
Quinine is a natural white crystalline alkaloid derived from the bark of the cinchona tree, 
native to the Andes mountain region in South America (Howard 2003). It was 
discovered in 1737 by Charles Marie de La Condamine and was the first effective 
treatment for malaria caused by Plasmodium falciparum. Until the 1940s quinine was the 
only known drug in western medicine for the treatment and prevention of malaria, after 
which, new more effective synthetic antimalarial drugs were developed and took over. 
Quinine was the first successful chemical compound ever used to treat an infectious 
disease, and more people have benefited from it than from any other drug in history. 
Today, quinine is the drug of choice for chloroquine resistant or severe P.flaciparum 
malaria (Huston 2006). Antimalarial drugs can be used for prophylaxis or treatment of 
malaria. The clinical indication of quinine is only for treatment and has no role in 
prophylaxis (AlKadi 2007). As a monotherapy quinine is given for 7 days to achieve 
cure, however due to its unpleasant adverse effects patient adherence is poor (Taylor W 
2004). Treatment with quinine is often associated with cinchonism, hypoglycaemia and 
hypotension, which are dose-related toxicities. Cinchonism usually occurs after several 
days of therapeutic use or an overdose of quinine. It consists of visual and hearing 
disturbances, abdominal pain, diarrhoea, vomiting, mental status changes, fever, flushed 
skin and vertigo. Cinchonism is a reversible syndrome (Huston 2006). Other common 
adverse affects of quinine are nausea, diarrhoea, headache tinnitus, dysphoria and 
blurred vision. Quinine causes toxicity in humans at approximately <2mM, causing 
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severe adverse affects such as retinopathy, hypoglycaemia, ototoxicity, hearing loss and 
thrombocytopenia Severe hypotension frequently occurs if the quinine is injected too 
rapidly (AlKadi 2007).  
The mechanism by which quinine causes this toxicity in humans is not understood, and 
identifying this is important as then related compounds that do not have such an effect 
could be selected. 
 
                
                        
1.2 Chemical structure of Quinine  taken from www.wikipedia.org 
 
1.3 Chloroquine 
Like quinine, chloroquine is also an anti-malarial drug. It is effective against 
Plasmodium vivax, Plasmodium ovale, Plasmodium malariae and drug sensitive 
Plasmodium falciparum (AlKadi 2007). Chloroquine is used as prophylaxis or treatment. 
Quinine is used for treatment of strains of the malarial parasite Plasmodium falciparum 
that have developed resistance to chloroquine.  The intraerythrocytic stages of 
P.falciparum are responsible for the clinical manifestation of malaria and are the target 
of chloroquine. These stages feed on the haemoglobin in erythrocytes, which is digested 
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by lysosomes, producing the toxic by product, ferriprotoporphyrin (FP) or heme, which 
is detoxified by dimerization to  into non-toxic ȕ-hematin (Fitch 2006) (Sanchez CP 
1997). ȕ-hematin (or hemozoin) collects in the lysosome as insoluble crystals. This 
detoxification of FP is inhibited by chloroquine in the lysosomes. ȕ-hematin molecules 
are capped by chloroquine to prevent further detoxification of FP, causing it to 
accumulate to lethal levels. In vivo experiments have demonstrated that significantly less 
chloroquine was accumulated in chloroquine resistant parasites than those that were 
sensitive to chloroquine. It has been proposed that this reduced accumulation of 
chloroquine is thought to provide resistance suggesting that resistant parasites are able to 
lower the concentration of chloroquine in the lysosomes to below than that which is 
required for heme polymerisation (Sanchez 1997). Membrane function is disrupted when 
chloroquine binds to FP forming a highly toxic complex called the FP-chloroquine. 
Action of this toxic complex and FP causes cell lysis and ultimately results in parasite 
cell auto-digestion. Due to its low cost and tolerability, chloroquine continues to be used 
despite its decreasing efficiency against P.falciparum. Chloroquine resistant P.vivax is 
also emerging (Taylor 2004). Unlike quinine, chloroquine is normally well tolerated. 
Mild side effects of include headache, mild gastrointestinal upset, malaise and nausea. 
However, long term chloroquine use can lead to severe adverse effects such as 
retinopathy and neuromyopathy. For treatment of malaria, chloroquine is administered 
once daily. Weekly chloroquine is used for prophylaxis alone or in combination with 
proguanil. Chloroquine causes acute toxicity in humans at <3mM, causing vomiting, 
convulsions, cardio-respiratory arrest, drowsiness and shock. This toxicity is most 
frequently encountered when therapeutic or high doses are administered too rapidly by 
parenteral routes (AlKadi 2007). The mechanism, by which chloroquine causes this 
toxicity in humans is not understood, and identifying this is important as then related 
compounds that do not have such an effect could be selected. 
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1.3 Chemical structure of Chloroquine  taken from www.wikiepedia.org 
 
1.4 Furan 
Furan is a heterocyclic organic compound typically derived by the thermal 
decomposition of pentose containing materials. It is a toxic, highly volatile, flammable, 
colourless liquid and has a boiling point close to room temperature. Furan is insoluble in 
water but soluble in alcohol and organic solvents. Since the 1970’s the occurrence of 
furan in some food items has been known; since then, a survey conducted by the US 
Food and Drug Administration (FDA) found furan to occur in a variety of foods, 
particularly canned and jarred products that undergo heat treatment. The mechanism of 
furan formation in foods is still unknown, although it has been proposed that thermal 
degradation of carbohydrates is a possible route. The presence of furan in so many food 
items has made it more important to clarify its toxicological properties (Durling 2007).  
Furan is carcinogenic in rats and mice, and has been classified as a possible human 
carcinogen (Peterson 2006). Studies have suggested both non-genotoxic and genotoxic 
pathways as possible mechanisms behind the carcinogenic effect of furan (Durling 
2007). Furan and furan compounds are cytotoxic, most frequently targeting the liver, 
lungs and kidneys causing necrosis. Organ specificities have been observed in some 
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furan compounds. Based on necrosis development, furan was found to be equally toxic 
to the liver and kidney in acute short term studies where 100 to 300 mg/kg of furan was 
intraperitoneally administered to mice over a 48 hour period. In the same experimental 
system 2-ethyl furan was found to be more toxic to the kidney than the liver whereas 
furosemide was found to be more toxic to the liver than to the kidney (NTP 1993) 
Studies have shown a dose-dependent increase in hepatocellular adenomas and 
carcinomas at 30mg/kg – 60mg/kg (Heppner 2007). The mechanism of tumour induction 
is unknown, however furan hepatoxicity is initiated following bio-activation by 
cytochrome P450 2E1-catalyzed oxidation to cis-2-butene-1,4-dial (Kedderis 1996). Cis-
2-butene-1, 4-dial is a cytotoxic metabolite which binds to nucleosides and proteins. 
Metabolism studies have shown that this reactive metabolite is formed in vivo and is also 
an intermediate that leads to other metabolites whose role in furan derived toxicities is 
yet to be discovered (Peterson 2006). The data available shows that there is a relatively 
small difference between the doses required to produce carcinogenic effects in 
experimental animals and possible exposure to humans (Heppner 2007). Due to the high 
occurrence of this compound in foods it is important to identify its toxicological effects 
in humans. Studies that have been carried out in rodents have not been able to 
successfully determine the mechanism of furan toxicity. 
 
                                          
1.4 Chemical structure of Furan  taken from www.wikipedia.org 
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1.5 DDT 
DDT is a colourless crystalline solid, best known for its insecticidal properties. It is an 
organochlorine insecticide first synthesised by Othmar Zeidler, in 1874, however it was 
only identified as an insecticide in 1939 by Paul Hermann Müller. DDT is a highly 
effective insecticide which affects the neurons. It acts on the voltage gated sodium 
channel proteins in nerve cell membranes. These proteins are integral membrane proteins 
and are responsible for the conduction of sodium ions. During an action potential the 
sodium channel undergoes transitions between open and closed in response to changes in 
the membrane potential. DDT binds to these sodium channels in the open state which 
inhibits its transition to the non-conducting deactivated state. Thus the channel is kept 
open and there is a prolonged inward conductance of sodium causing repetitive nerve 
firing which leads to paralysis and death of the insect. Resistance to DDT is seen in 
insects with particular point mutations in the sodium ion channel gene. In some insect 
species, the up-regulation of genes expressing cytochrome P450 also results in DDT 
resistance. DDT was the insecticide widely used for malaria vector control programmes; 
however its use has gradually declined due to concerns for the environment, and 
development of vector resistance. There are no sodium channels recognised in C.elegans 
and the mechanism by which DDT causes toxicity is not understood as the channel that 
mediates sodium transport is unknown. 
                             
1.5 Chemical structure of DDT  taken from www.wikipedia.org 
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1.6 Deltamethrin 
Deltamethrin is a widely used pyrethroid ester insecticide. It is a synthetic pyrethroid, 
and considered to be one of the safest classes of pesticides.  
Like DDT, the target for deltamethrin is voltage-gated sodium channels; disturbing the 
ionic exchanges during nerve impulses. In insects pyrethroids cause severe paralysis 
(knockdown) (Daaboub 2008). At operational doses, deltamethrin has relatively low 
toxicity in mammals, with exposure to mammals classified as safe. Deltamethrin has 
quick knockdown effects and high insecticidal potency; it is highly toxic to aquatic life, 
particularly fish. Non-bioaccumulation and efficiency against arthropods with resistance 
to cyclodienes, carbamates and organophosphate insecticides make deltamethrin and 
pyrethroids suitable for veterinary and public health purposes (Daaboub 2008). 
Widespread use of pyrethroids has seen an increase in pyrethroid resistance in many 
insect species. Target site insensitivity (or resistance) to deltamethrin is acquired by a 
point mutation in the insects voltage-gated sodium channel proteins (Perera 2008). Over 
20 unique polymorphisms in the amino acid sequence of sodium ion channels have been 
associated with resistance to pyrethroids. (Hemingway 2004). The most common 
mutation identified is a substitution at position 1014 of leucine to phenylalanine in the 
S6 segment of domain II of the sodium channel gene (Daaboub 2008). This mutation has 
been identified in mosquitoes and other insect species resistant to pyrethroids.  Another 
mechanism conferring pyrethroid resistance is increased activity of detoxification 
enzymes such as carboxylesterases; however this often has effects on fitness. 
Deltamethrin has played a key role in controlling malaria vectors and preventing the 
spread of diseases carried by rodents and prairie dogs infested by ticks as well as other 
burrowing animals. It is also used in the manufacture of mosquito nets, where the net is 
saturated with deltamethrin. Studies have shown that mosquito resistance to deltamethrin 
is correlated with resistance to DDT, suggesting there may be cross resistance between 
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the two insecticides. There are no sodium channels recognised in C.elegans and the 
mechanism by which deltamethrin causes toxicity is not understood, as the channel that 
mediates sodium transport in C.elegans is unknown. 
 
1.6 Chemical Structure of Deltamethrin  taken from www.wikipedia.org 
 
1.7 The Lat-1 (ok1465) C.elegans 
The latrophilin protein, encoded by the lat-1 gene is a member of the secretin/calcitonin 
family of G-protein coupled receptors. It was first isolated from bovine membranes and 
is mostly found in neuronal or neuroendocrine tissues (Adenle 2008). Latrophilin is the 
major protein to bind Į-latrotoxin. Ligand binding to the latrophilin receptor triggers an 
intracellular signalling cascade. 
The lat-1 (ok1465) has a 2209bp deletion of the lat-1 gene  that removes exons 3, 4 and 
5 and inserts an AT encoding a truncated protein and lacks the first transmembrane 
domain (Guest 2007). This deletion renders latrophilin dysfunctional. Approximately 
97% of these worms die before adulthood, with only 2-3 adult offspring per animal. 
Studies have shown that the lat-1 gene is essential for embryonic and larval development 
and this lethality is due to the deletion in the lat-1 gene. Adenle, (2008) found that 33% 
of lat-1 (ok1465) offspring had embryonic lethality and 65% larval lethality, whereas in 
wild-type offspring 100% survived to adulthood. The phenotype of lat-1(ok1465) animal 
offspring is characterised by the failure of gut attachment to pharynx in larvae and 
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failure of epithelial migration. Due to the lethality of the lat-1 (ok1465) allele, it is 
balanced with a mIn gene, where it is maintained as a stable heterozygote mIn/lat-1, 
which has a wild-type phenotype. The mIn gene is tagged with dumpy (dpy) and green 
fluorescent protein (gfp). A selfed mIn/lat-1 worm will produce offspring of mIn/mIn, 
mIn/lat-1 and lat-1/lat-1 genotypes. C.elegans carrying the mIn gene have a fluorescent 
pharynx; but homozygous mIn/mIn worms also express a recessive dumpy (short and 
fat) phenotype. Homozygote lat-1 worms are of a normal size but are not fluorescent. 
These differences can be identified under a microscope using a gfp filter. 
                          
Figure 1.7 A photograph taken under a microscope using the gfp filter, showing the 
green fluorescent pharynx phenotype seen in C.elegans carrying the mIn gene. 
 
1.8 Summary / Aim of the study. 
Chloroquine and quinine are both antimalarial drugs, still widely used today, for the 
treatment and prophylaxis of malaria. The mechanism of action of the drugs on the 
malaria causing strains of Plasmodium has been demonstrated in experiments in vivo; 
however the pathway of toxicity in humans is still unclear and C.elegans are used in this 
study to help determine the genes that may be involved in this pathway. 
Furan is a highly toxic, volatile organic compound which is carcinogenic in rats and 
mice and is thought to be a possible human carcinogen. Furan is present in a variety of 
foods, with the highest levels found in jarred and canned products, and is formed during 
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the heat-treatment of food. Due to the high occurrence of this compound in foods it is 
important to identify its toxicological effects in humans. Studies that have been carried 
out in rodents have not been able to successfully determine the mechanism of furan 
toxicity. In this study C.elegans are used as a model for rodent toxicity.  
DDT and Deltamethrin are potent synthetic insecticides widely used in agriculture today. 
These insecticides have had a significant impact in the control of malaria and other 
insect borne diseases. DDT and Deltamethrin act on the sodium ion channels in neurons 
by opening them, which therefore cause them to fire spontaneously which lead to spasms 
and eventually death. Little is known about the pharmacology of these insecticides and 
how they work in C.elegans. There are no sodium channels recognised in C.elegans and 
the channels that mediate sodium transport is unknown, and in this study the C.elegans is 
used to try identify this. 
Toxicity assays will be used in this study to test how the above compounds effect the 
growth, brood size and lethality of C.elegans by exposing them to various concentrations 
of each compound. Once a phenotype is established for how the C.elegans are affected 
by each compound, a mutagenesis can be performed to screen and select for mutants that 
are a resistant to the effects of the compound, and gene mapping would be used to 
identify these mutations. The hypothesis is that the mechanism by which these toxins 
exert their toxic effects on C.elegans would be the same as for mammals and 
invertebrates.   
The lat-1 (ok1465) C.elegans have a deletion in the lat-1 gene and ~ 97% homozygous 
worms die before reaching adulthood. In this study the lat-1(ok1465) C.elegans will be 
crossed with the Hawaiian (CB4856) C.elegans for 6 generations to produce a strain with 
the ok1465 allele in a Hawaiian C.elegans background. A mutagenesis could then be 
performed to screen and select for mutants that did not have 97% lethality. Gene 
mapping would then be used to identify these mutations. 
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2. Materials and Methods 
LB Agar, LB Broth and Agar were obtained from Melford laboratory Ltd. Peptone, 
Gelatine, Tween 20, TEMED, Ethanol, Quinine, DDT, Sodium azide, Deltamethrin, 
Furan, Chloroquine, DMSO and Acetone were obtained from Sigma. Primers were from 
Eurofins. 100bp ladder was from New England Biolabs. The PCR master mix was 
obtained from Thermo Scientific. All other chemicals or compounds were from Fisher 
Scientific unless otherwise stated. 
 
2.1 Reagents 
All solutions were made up to 1 litre with UHP water and sterilized by autoclaving. 
Storage was at room temperature unless otherwise stated.  
 
Nematode Growth Medium (NGM) agar. 
NaCl – 3.0g 
Agar – 17.0g 
Peptone – 2.5g 
Cholesterol (5mg/ml ethanol) – 1ml 
 
S- Basal  
NaCl – 5.84g 
Potassium Phosphate Buffer – 50ml 
 
Potassium Phosphate Buffer (pH 6.0)  
1M KH2PO4 – 434ml 
1M K2HPO4 – 66ml 
The above volumes mix to make the buffer pH6. 
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LB Broth  made up using 25g of a ready mix. 
Tryptone – 10g 
NaCl – 10g 
Yeast extract – 5g 
 
LB Agar  made up using 35g of a ready mix. 
Tryptone – 10g 
NaCl – 10g 
Yeast extract – 5g 
Micro Agar – 10g 
 
Sodium azide  dissolved in H20, made up to 1ml each at the following concentrations 
by serial dilution. 
1M, 0.1M, 0.01M, 0.001M, 0.0001M. 
 
Chloroquine  dissolved in H20; 150mM stock solution made up to 10ml, this was 
diluted to make 1ml each of the following concentrations. 
125mM, 100mM, 30mM, 10mM  
Chloroquine was stored at -20ºC. 
 
Furan  150mM stock solution made up to 10ml in 100% ethanol, this was diluted to 
make 1ml each of the following concentrations. 
125mM, 100mM, 30mM, 10mM. 
Furan was stored at 4ºC. 
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Quinine  250mM stock solution made up to 2ml in 100% ethanol, this was diluted to 
make 1ml each of the following concentrations. 
250mM, 100mM, 30mM, 10mM 
Quinine was stored at -20ºC. 
 
DDT  stock solution made up to 1mg/ml in 100% DMSO this was serially diluted to 
make up 1ml each of the following concentrations. 
0.1mg/ml, 0.01mg/ml, 0.001mg/ml, 0.0001mg/ml. 
DDT was stored at -20ºC. 
 
Deltamethrin  stock solution made up to 1mg/ml in 100% DMSO this was serially 
diluted to make 1ml each of the following concentrations. 
0.1mg/ml, 0.01mg/ml, 0.001mg/ml, 0.0001mg/ml 
 
Lysis Buffer  made up to 100ml as described. 
Tris-HCL (pH 8.0) – 1ml 
KCL – 0.37275g  
MgCl2 – 0.0508275g 
IGEPAL (Nonidet P40) - 450µl 
Tween 20 - 450µl 
Gelatin - 10µg 
Protienase-K (Stock 10mg/ml) - 500µl (to give 50µg/ml) 
Proteinase-K must be kept frozen so once added, 10µl of the solution were aliquot into 
500 µl  
PCR tubes and stored at -20°C. 
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12% TBE-PAGE Gel  made up to 100ml as described. 
Polyacrylamide (30%) - 40ml 
H2O – 50ml 
10 x TBE – 10ml 
TEMED - 100µl 
This solution was kept at 4ºC, and the following was added when assembling a gel. 
Ammonium phosphate (Stock 0.1g/ml) - 10µl per ml of 12% TBE page gel. 
Ammonium phosphate (APS) stock was aliquot to fill 1.5ml centrifuge tubes and stored 
at -20°C. 
 
TBE  this was made up as a 10X concentrate. 100ml of the concentrate was then made 
up to 1 litre. 
Tris – 108g 
Bomic Acid – 55g 
0.5M EDTA (pH 8.0) – 40ml 
 
Freezing Solution 
NaCl – 5.85g 
KH2PO4 – 6.8g 
Glycerol – 300g 
1M NaOH – 5.6ml 
0.1M MgSO4 – 3ml (this was only added after autoclaving). 
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PCR Master Mix  Ready to use, each vial contains 1.8ml at a 1.1x working 
concentration. 
Thermoprime plus DNA polymerase – 1.25 units 
Tris-HCL (pH8.0) – 75mM 
(NH4)2SO4 – 20mM 
MgCl2 – 1.5mM 
Tween 20 – 0.01% (v/v) 
dATP, dCTP, dGTP and dTTP each at – 20mM 
The master mix was stored at 4°C. 
 
Loading Buffer  made up to 10ml 
Glycerol – 5ml 
Bromophenol blue – 25µl 
Xylene cyanol FF – 25µl 
10 X TBE – 1ml 
 
Primers – made as per company instructions to 100pm. 
Lat1 ok1465 null 5 
5’- AGC TTG GTC AGG GTA GTA CT – 3’ 
Lat1 ok1465 null 3 
5’ GGT TTT TGG TCC AAA TTT CGA CC – 3’ 
Lat1 ok1465 wild-type 5 
5’ – TTC ACA TTC ATT GTG ATG GA – 3’ 
Lat1 ok1465 wild-type 3 
5’ – TCC GGT AAT CCA GAG ACA TC – 3’ 
 28
To avoid repeat freeze-thawing, primers were aliquot (15µl) into PCR tubes and stored at       
-20°C. 
 
Egg Isolation Bleach Solution  made up to 24 ml as described. 
NaOCl (stock at 13%) – 3ml 
NaOH (1M) – 6ml 
H2O – 15ml 
 
2.2 General Methods 
2.2.1 E.coli cultures. 
E.coli OP50 cells were grown up in LB broth medium. LB agar (section 2.1) was 
microwaved for 10-15 minutes until molten and poured under sterile conditions in a 
class II hood to make LB agar plates. These plates were then streaked with a single 
colony of OP50 E.coli and incubated at 37ºC overnight. (Only one plate was streaked at 
a time, the remaining LB agar plates were sealed and stored at 4ºC) A single colony from 
this plate was used to inoculate 5ml of LB broth (section 2.1) in a universal (20ml) tube 
under sterile conditions in a class II hood. This was grown overnight at 37ºC and 
240rpm. OP50 E.coli plates and liquid media were stored at 4°C. A new LB agar plate 
was streaked with OP50 E.coli every 4 weeks.  
 
2.2.2. Gel electrophoresis. 
TBE-PAGE gel was made up as described in section 2.1. 5.5ml of this solution was 
poured into a gel casting mould and allowed to set with a comb of 10 wells.  When set, 
the comb was removed and the gel was placed in an electrophoresis tank filled with 1x 
TBE buffer. 3µl of loading buffer (section 2.1) was added to each of the DNA samples 
and gently mixed. The DNA samples were carefully loaded into the wells of the gel 
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alongside a 100bp DNA ladder as a marker. The gels were run using the Bio-Rad gel 
system for 1.5 hours at 100V. The gel was then removed from the mould and placed in a 
solution of 0.0001% ethidium bromide in H20 for 30 minutes and washed with H20 for a 
further 10 minutes. The gel was visualised under UV trans-illuminator, and 
photographed using Bio Rad Gel-Doc system and the Quantity One software. 
 
2.3 General methods for C.elegans 
2.3.1 Maintenance of C.elegans 
C.elegans were grown and maintained on NGM agar plates seeded with an OP50 E.coli 
lawn at 15°C throughout the study. NGM was prepared as described in section 2.1. After 
autoclaving the solution was microwaved until molten and allowed to cool to 65ºC. The 
NGM plates were poured into 3cm or 9cm under sterile conditions in a class II hood, 
until ½ full. Once the agar was set, a drop of OP50 E.coli was placed in the centre of 
each of the plates. A flamed glass spreader was used to evenly spread the E.coli on 9cm 
plates. The plates were left to air-dry under sterile conditions and incubated overnight at 
37ºC. Plates were stored at room temperature. 3cm plates were used for breeding, and 
9cm plates were used for keeping C.elegans stocks. These plates were chunked when 
plates were overcrowded or worms became starved. Chunking involves using a sterile 
heat flamed stainless steel scalpel, to cut out and transfer a chunk of an old starved NGM 
plate of C.elegans to a new plate. C.elegans were handled using a worm pick; which is a 
platinum wire heat sealed to the end of glass pipette. 
 
2.3.2 Microscopy of C.elegans 
C.elegans were viewed using a Wild M3 stereo microscope, at 6.4X, 16X and 40X 
magnification. Fluorescent worms were viewed using the Olympus SZX12 stereo 
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microscope (using a gfp filter) and worms from the L1 growth assay, were viewed on 
microscope slides using the Axiovert 135TV inverted microscope. 
 
2.3.3 Egg Isolation  
1. A plate of gravid hermaphrodite C.elegans was washed with 2-3mls of S-basal and 
0.5ml was transferred using a pipette to a 1.5ml centrifuge tube.  
2. 0.5ml of the egg isolation bleach solution was added to the centrifuge tube, and a 
timer was started. 
3. The centrifuge tube was immediately closed and mixed by vortexing at the maximum 
speed for 3 minutes. 
4. It was then spun in a centrifuge held at 4ºC for 1 minute at 500g. A 1.5ml centrifuge 
tube filled with an equal volume of H2O was used as a balance. 
5. After spinning, the supernatant was carefully discarded ensuring not to disturb the 
pellet and fresh S-basal was added to fill the centrifuge tube. A 1.5ml centrifuge tube 
filled with an equal volume of H2O was used as a balance. 
6. Steps 4 and 5 were repeated for three further spins. 
7. After the final spin the supernatant was discarded and the pellet re-suspended in         
s-basal a final time. 
8. The solution is then transferred to a 6-well plate using a sterile Pasteur pipette. 
9. All steps were then repeated until all the wells in the 6-well plate are full. 
10. The 6-well plate is sealed with laboratory film and incubated at 15°C overnight for 
the eggs to hatch into larvae. 
 
2.3.4 Freezing worms 
C.elegans worms can be frozen and stored at -80ºC for an indefinite period of time. 
Starved L1 animals are most likely to survive this freezing; whereas adult and well fed 
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animals do not survive.(Dawe 2004) In order to obtain starved animals worm 
populations to be frozen, are either bleached to obtain starved L1 larvae or allowed go 
grow on plates until the OP50 E.coli was exhausted.  Plates with starved C.elegans 
worms were washed with 2-3ml of S-basal using a Pasteur pipette, into a 5ml tube. An 
equal volume of freezing solution (section 2.1) was added and mixed by inverting 
several times. 1ml aliquots were dispensed into 1.5ml cryotubes. The tubes were closed, 
labelled and frozen at -80ºC. 
 
2.4 C.elegans toxicity assays. 
These methods are based on Bischof et al (2006) taken from C.elegans: Methods and 
applications; Methods in Molecular Biology.  
2.4.1 L1 growth assay 
This assay is to measure the effect of toxins on growth and development of C.elegans. 
The assay is set up and run over 4 days.  
 
1. On day 1 5ml of LB broth was inoculated with a single colony of E.coli OP50, and 
incubated overnight at 37ºC and 240rpm. A plate of gravid hermaphrodite worms were 
bleached as described in section 2.3.3. 
 
2. On day 2, 1ml of the OP50 bacterial culture was spun for 5 minutes at 2000g. The 
supernatant was discarded and the pellet was re-suspended in S-basal medium. 
 
3.  L1 worms were spun for 1 minute at 500g. The supernatant was discarded and the 
pellet was re-suspended in s-basal with a volume sufficient to give 6-8 worms/µl. The 
number of worms in a 5µl sample was counted. If the worms were too concentrated        
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s-basal was added until there were 30-40 worms per 5µl. If the worms were too diluted, 
they were re-spun and the appropriate amount of supernatant was removed. 
 
4. The absorbance of the bacterial culture was measured at 600nM. The absorbance was 
adjusted to be 0.70, by adding S-basal. The spectrophotometer was zeroed using S-basal. 
 
5. The assay was set up in a 24-well plate, with 3 wells for each concentration. Each well 
contained 5µl of L1 worms in s-basal (30-40 worms in total), 40µl of E.coli OP50 
bacterial culture in s-basal, the toxin and s-basal to make a total volume of 400µl. 
 
6. The toxin was made up to give a range of doses in order to obtain a response curve. 
The toxin was serially diluted to prepare 100X stocks of each concentration to be tested.  
 
7. A master cocktail was made up for each concentration, sufficient for 4 wells, 
combining the bacterial culture, s-basal medium and L1 worms. (See appendix for 
volumes added.) This was then repeated for the rest of the concentrations and the 
control. 
 
8. Once the cocktail was aliquot into the wells, the toxin was added. (See appendix for 
volumes added.) S-basal was added to control wells in place of the toxin. 
 
9. The 24-well plate was then sealed with laboratory film (to prevent evaporation), 
wrapped in a damp paper towel (to provide humidity) and placed in an air tight plastic 
container. The assay was incubated at 15ºC for 3 days. 
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10. After 3 days, 4µl of 1M Sodium azide was added to each well in order to immobilise 
the worms. 
 
11. The contents of each well was transferred into 1.5ml centrifuge tubes and spun for 1 
minute at 500g. The supernatant was removed leaving approximately 10-20µl. the pellet 
was re-suspended by briefly vortexing 
 
11. Agarose pads were prepared on microscope slides using a 2% (w/v) agarose solution. 
A microscope slide was aligned in between two microscope slides with tape adhered to 
the surface. (See figure 2.4.1 below) Using a Pasteur pipette, 2 drops of agarose was 
placed on the middle slide and another slide was quickly placed on top of the agarose 
drops in a   perpendicular orientation, as shown below. Once the agarose had set (after 
approximately 1 minute) the top slide was removed. This was then repeated to make the 
rest of the agarose pad microscope slides. Each slide was labelled with a concentration. 
 
T
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Figure 2.4.1 Preparation of agarose pads on microscope slides 
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12. The worms were gently mixed by hand and then 5-7µl was carefully pipetted onto 
the agarose pad, making sure it was for the correct concentration. A coverslip was then 
gently placed on top. 
 
13. The worms were then imaged with a 10X objective using an inverted microscope and 
photographed using a Scion 1310M CCD camera and the Visicapture software. The 
worm images were saved as .tiff files and a minimum of 30 worms were photographed 
per concentration. 
 
14. The worms’ sizes were then measured in pixels using Adobe Photoshop CS3 and the 
magnetic lasso tool. 
 
 
 
Figure 2.4.2 An example of a worm that has been photographed and outlined using the 
magnetic lasso tool in Adobe Photoshop CS3. The outlining is as close as possible to the 
edge of the worm’s body. 
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15. The measurements recorded in pixels were converted to mm2 by photographing a 
haemocytometer (of known area) in the same manner. The photographed area was then 
also measured in pixels. The measurement in pixels was divided by the measurement in 
mm2 to obtain the number of pixels per mm2. The number of pixels per mm2 is 
1,709,750. All the worm measurements were converted to mm2 in this way. 
 
16. An identical assay was set up and run alongside, with Sodium azide (see appendix) 
as a positive control. 
 
2.4.2 Brood size assay. 
This assay is to measure the effect of toxins on brood size. The assay is set up and run 
over 8 days.  
 
1. On day 1 a plate of gravid adult worms were bleached as described in section 2. 3.3 
 
2. On day 2 L1 worms were plated on an NGM plate seeded with E.coli OP50 and 
incubated at 15ºC for 3 days. The worms will be at the L4 stage of growth. 
 
3. On day 4, 5ml of LB broth was inoculated with a single colony of E.coli OP50, and 
incubated overnight at 37ºC and 240rpm. 
   
4. On day 5, 1ml of the OP50 bacterial culture was spun for 5 minutes at 2000g. The 
supernatant was discarded and the pellet was re-suspended in S-basal medium. 
 
5. The absorbance of the bacterial culture was measured at 600nM. The absorbance was 
adjusted to be 0.70, by adding S-basal. The spectrophotometer was zeroed using s-basal. 
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 6. The assay was set up in a 48-well plate, with 3 wells for each concentration. Each well 
contained a single L4 worm, 40µl of bacterial culture, the toxin and s-basal to make a 
total volume of 400µl. 
 
7. A master cocktail was made up for each concentration, sufficient for 4 wells, 
combining the bacterial culture and S-basal medium. (See appendix for volumes added.) 
This was then repeated for the rest of the concentrations and the control. 
 
8. Using the worm pick, a single L4 worm was picked from the NGM plate and placed in 
each well. The worm pick was sterilised in a flame after each worm was placed. 
 
9. Once all the worms had been transferred, the toxin was added. See appendix for 
volume of toxin added to each well for each concentration. 
 
10. The 48-well plate was then sealed with laboratory film (to prevent evaporation), 
wrapped in a damp paper towel (to provide humidity) and placed in an air tight plastic 
container. The assay was incubated at 15ºC for 3 days. 
 
11. After 3 days the number of progeny in each well was counted under a stereo 
microscope. 
 
12. An identical assay was set up and run alongside, with Sodium azide (see appendix) 
as a positive control. 
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Due to the short generation time of C.elegans only the partial brood size was measured 
after 3 days. After 3 days the early progeny would start having progeny of their own 
which would make scoring difficult. In order to measure the full brood size over 5-6 
days the worms would have to be transferred to new wells after the third day. It was 
therefore more feasible to perform this assay over three days to avoid the need of 
transferring the parental worm. 
 
2.4.3 Lethality assay. 
This assay is to measure the effect of toxins on lethality. This assay is set up and run 
over 8 days. 
 
1. On day 1 a plate of gravid hermaphrodite worms were bleached as described in 
section 2.3.3 
 
2. On day 2 L1 worms were plated on an NGM plate seeded with E.coli OP50 and 
incubated at 15ºC for 3 days. The worms will be at the L4 stage of growth. 
 
3. On day 4, 5ml of LB broth was inoculated with a single colony of E.coli OP50, and 
incubated overnight at 37ºC and 240rpm. 
   
4. On day 5, 1ml of the OP50 bacterial culture was spun for 5 minutes at 2000g. The 
supernatant was discarded and the pellet was re-suspended in S-basal medium. 
 
5. The absorbance of the bacterial culture was measured at 600nM. The absorbance was 
adjusted to be 0.70, by adding S-basal. The spectrophotometer was zeroed using S-basal. 
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6. L4 worms were collected in a 1.5ml centrifuge tube by washing the NGM plate with 
1-2ml of s-basal and spun for 1 minute at 500g. The supernatant was discarded and the 
pellet was re-suspended in s-basal with a volume sufficient to give approximately 10 
worms/µl. The number of worms in a 5µl sample was counted. If the worms were too 
concentrated s-basal was added until there were 50 worms per 5µl. If the worms were 
too diluted, they were re-spun and the appropriate amount of supernatant was removed. 
 
7. The assay was set up in a 24-well plate, with 3 wells for each concentration. Each well 
contained 5µl of L4 worms in s-basal (20 worms in total), 40µl of E.coli OP50 bacterial 
culture in s-basal, the toxin and s-basal to make a total volume of 400µl. 
 
8. A master cocktail was made up for each concentration, sufficient for 4 wells, 
combining the bacterial culture, S-basal medium and L4 worms. (See appendix for 
volumes added.) This was then repeated for the rest of the concentrations and the 
control. 
 
9. Once the cocktail was aliquot into the wells, the toxin was added. (See appendix for 
volumes added.) S-basal was added to control wells in place of the toxin. 
 
10. The 24-well plate was then sealed with laboratory film (to prevent evaporation), 
wrapped in a damp paper towel (to provide humidity) and placed in an air tight plastic 
container. The assay was incubated at 15ºC for 3 days. 
 
11. After 3 days the percent alive was determined by counting the number of viable 
worms in each well based on movement. 
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12. An identical assay was set up and run alongside, with Sodium azide (see appendix) 
as a positive control. 
 
2.4.4 Vehicle control assays. 
Vehicle control assays were set up alongside the above three assays for each toxin tested. 
These assays were set up and analysed as described above for each type of assay. The 
vehicle was only tested if it was not H2O. The sodium azide positive control assay set up 
along side the each toxicity assay was also used as the positive control for the vehicle 
control assay. 
 
2.5 Data presentation and statistics. 
Microsoft Excel was used to calculate the mean and standard deviation of the data and 
the log10 concentration. These values were analysed by the GraphPad Prism 5 software 
which was used to generate all graphs. The data was fit to a linear non regression curve 
with the settings log [agonist] vs. response. The top and bottom value constraints were 
set as the start size and maximum measurements for the growth curves. The bottom 
constraint value was set as the maximum brood size for the toxin tested and the top 
constraint value was set as 0 for all brood size curves. The constraint values for the dose-
response curves were set as 100 for the bottom and 0 for the top for all toxins. The IC50 
and 95% confidence intervals for all the toxicity assay results were calculated by the 
Graphpad Prism software.   
 
Statistical analysis was carried out to determine if the difference between the treated and 
the control was statistically significant. A t-test was done on results that did not show an 
obvious difference from the control value. If the t value was below the threshold of 0.05 
(5%) the null hypothesis was rejected. The null hypothesis was that there is no difference 
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between the two values. Therefore if the null hypothesis was rejected then the difference 
between the two values is statistically significant. However, if the t value was above the 
0.05 (5%) threshold, the null hypothesis was accepted, and the difference between the 
two values is not statistically significant. 
 
2.6 Polymerase chain reaction (PCR) 
1. A single worm was picked from a plate using a flamed titanium worm-pick and 
transferred into a 500µl PCR tube with 10µl of lysis buffer.  
 
2. In order to lyse the worm and isolate the genomic DNA, it was then frozen for 1 hour 
at -80°C and then heated for 6 hours at 65°C and 1 hour at 95°C. The proteinase-k is 
active at 65°C but is de-activated at 95ºC. This heat-deactivation is crucial as the 
proteinase-k can cleave the polymerase during the PCR reaction. 
 
3. Each PCR reaction contained 2µl of the DNA solution, 1µl of each 5’ and 3’ 
100pmole primers (see section 2.1 for sequence) and 26µl of PCR master mix. These 
were set up in a PCR hood using filter-tips to prevent cross contamination. 
 
4. The PCR reaction was carried out in a Progene thermal cycler and optimised for the 
following conditions. 
 
94°C for 30 seconds - Denaturing 
 
54ºC for 30 Seconds - Annealing 
 
72°C for 1 minute – Elongation 
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This was done for 35 cycles. 
Prior to cycling the PCR reaction was heated for 2 minutes at 94°C, this is an 
initialisation step and is required for the heat activation of DNA polymerase.   
To confirm the amplification of the PCR product the PCR reaction was run on 12% 
polyacrylamide gel electrophoresis (PAGE) alongside a negative control and a DNA 
ladder as a marker. 
 
2.7 Breeding  
Breeding was carried out between the Lat-1 ok1465 C.elegans and the Hawaiian 
CB4856 C.elegans. 
1. The Lat-1 ok1465 C.elegans were isolated by allowing the mIn/lat-1 strain of 
C.elegans to self-fertilise which would produce homozygous lat-1 worms at a rate of 
approximately 1/100. The mIn/lat-1 C.elegans population was viewed under a 
microscope using a gfp filter. Homozygous lat-1 worms were identified from the 
mIn/lat-1 population as described in section 1.7. 
 
2. A few homozygous Lat-1 C.elegans were placed on a 10cm NGM agar plate seeded 
with OP50 and allowed to self-fertilise to produce a Lat-1 stock plate. 
 
3. CB4856 hermaphrodites were allowed to self-fertilise, which produced males at a 
frequency of 1/100. 6 males were picked using a flamed titanium worm pick and 
transferred onto a 3cm NGM agar plate seeded with OP50 E.coli, along with a single 
CB4856 L4 hermaphrodite. The plate was then incubated at 15ºC overnight.  
 
4. The following day the 6 males and hermaphrodite were transferred to another 3cm 
NGM plate seeded with OP50 E.coli. This was repeated for the following 2 days by 
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which time the progeny from the first day will be L4. If the breed was successful then 
approximately 50% of the progeny will be male. In order to produce more males, step 3 
was repeated using 6 males and 1 L4 hermaphrodite from this plate. Step 3 was repeated 
throughout the breed to produce males. 
 
5. Using a flamed titanium worm pick, 6 CB4856 males were placed on a 3cm NGM 
agar plate seeded with OP50 E.coli, along with a single L4 Lat-1 hermaphrodite picked 
from the Lat-1 stock plate using a flamed titanium worm pick. This plate was then sealed 
using laboratory film and incubated at 15°C overnight. 
 
6. The following day the hermaphrodite and 6 males were transferred to another 3cm 
NGM agar plate seeded with OP50 E.coli, using a flamed titanium worm pick. This was 
repeated daily until the progeny from the first day had grown to L4.  
7. If the breed was successful there will be more viable offspring and 50% of the 
offspring will be male. The genotype of all the F1 offspring will be Lat-1 +/-.  
Lat-1(-/-) Ƃ X CB4856 ƃ (+/+) 
          CB4856 
 
 
F1 + + 
_ -/+ -/+ 
_ -/+ -/+ 
Lat-1 
Figure 2.7.1 Punnett square showing genotypes for F1 offspring from a cross between a 
homozygous Lat-1 hermaphrodite and homozygous CB4856 male 
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8. An L4 hermaphrodite was picked from this plate and crossed with 6 CB4856 males as 
described in step 5. 
 
9. A successful breed was successful 50% of the offspring would be male and the F2 
offspring would be 50% genotype +/- and 50% genotype +/+.                 
      CB4856 
F2 + + 
_ -/+ -/+ 
+ +/+ +/+ 
    F1  
 
Figure 2.7.2 Punnett square showing genotype of F2 offspring from a cross between 
heterozygous F1 hermaphrodite and homozygous CB4856 male. 
 
10. From this F2 generation, 8 L4 hermaphrodites were selected at random and each was 
crossed with 6 CB4856 males as described in step 4. Each of the plates was labelled, the 
worms were transferred daily to new plates as described in step 5, and each plate was 
labelled. On the third day each of the 8 hermaphrodites were genotyped by PCR as 
described in section 2.6. The PCR products were run on 12% polyacrylamide gel 
electrophoresis along side a DNA marker and negative control to confirm amplification 
the PCR fragment, as described in section 2.2.2. The PCR was run with ok1465 null 
primers so the gel would only show a band to confirm the presence of a Lat-1 PCR 
fragment in a heterozygous +/- hermaphrodite and no band would be seen for 
homozygous +/+ hermaphrodites. If the breed was successful 50% of the offspring 
would be male. A heterozygote hermaphrodite would produce offspring with 50% 
genotype +/- and 50% genotype +/+. A homozygote hermaphrodite would produce only 
wild-type offspring of +/+ genotype. 
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                            CB4856                         CB4856 
F3 + + 
_ -/+ -/+ 
  + +/+ +/+ 
F3 + + 
+ +/+ +/+ 
+ +/+ +/+ 
 
    F2      F2  
Figure 2.7.3 Punnett squares showing genotype of F3 offspring from a cross between F2 
heterozygous and homozygous hermaphrodite and a homozygous CB4856 male. 
 
Any plates with offspring from a homozygote (+/+) hermaphrodite, were discarded. 
 
11. Step 10 was repeated, with L4 hermaphrodites from plates with F3 offspring from a 
heterozygote hermaphrodite. Step 10 was repeated until the F6 generation. 
  
12. F6 offspring from a heterozygote hermaphrodite were grown to L4. 15 of these L4 
hermaphrodites were each placed on a 3cm NGM plate seeded with OP50 E.coli and 
allowed to self for 3 days at 15ºC. Each day the C.elegans were transferred to a fresh 
plate. On the third day, these 15 F6 adult hermaphrodites were genotyped as described in 
step 10. A self-fertilised heterozygous (+/-) hermaphrodite would produce offspring of 
50% genotype (+/-), 25% genotype (+/+) and 25% genotype (-/-). A self-fertilised 
homozygous hermaphrodite would produce offspring of only wild-type genotype (+/+). 
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 + +  + - 
+ +/+ +/- 
_ +/- -/- 
+ +/+ +/+ 
+ +/+ +/+      
 
Figure 2.7.4 Punnett squares showing the genotype of offspring from a self-fertilized F6 
heterozygous hermaphrodite and a homozygous hermaphrodite. 
 
Plates with offspring from a homozygous hermaphrodite were discarded. 
 
13. All the offspring from heterozygous hermaphrodites were individually plated on to 
3cm NGM plates seeded with OP50 E.coli and allowed to self-fertilise for one week at 
15°C. 
 
14. Although 25% of the offspring should have been of lat-1 (-/-) genotype but, due to its 
characteristic 97% lethality during embryogenesis and larval development only 1-2 of 
the lat-1 (-/-) embryos from the heterozygous hermaphrodite would survive to adulthood. 
After three days all the plates were examined. A plate with a lat-1 (-/-) animal can be 
easily recognised as it will have many embryos but only 2-3 adult C.elegans. The 
majority of plates had many animals and were therefore either of heterozygous (+/-) 
genotype or homozygous (+/+) genotype and were discarded. 
 
15. When a plate with a lat-1 (-/-) animal was identified, it was left to grow at 15ºC for 5 
weeks to allow the population to grow to a sufficient number of worms. . This phenotype 
was confirmed by genotyping animals from this population as described step 10.  This 
population was then frozen and stored at -80ºC as described in section 2.3.4 
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3. Results 
3.1 C.elegans toxicity assays 
Three types of toxicity assays were used in this study and performed in liquid media. 
These include quantitative growth, brood size and lethal dose assays. The assays provide 
useful toxicological information about how/what effect toxins have on C.elegans at 
different stages in its life cycle. 
 
3.1.1 L1 growth assay 
L1 worms were exposed to various concentrations of a toxin for 3 days. The worms were 
photographed and measured to determine size and hence the concentration of compound 
which inhibited growth (if any). This assay measures the parameters of development as 
well as growth, and potentially allows for worms to progress through all four larval 
stages, which is unique to this assay. This assay can also detect if a toxin was more 
efficacious at a particular larval stage (Bischof 2006)  
 
3.1.2 Brood assay 
Individual L4 C.elegans were exposed to various concentrations of a toxin for 3 days. 
After 3 days, the brood size was counted to determine how the brood size is affected and 
at the concentration of compound which inhibited brood size (if any). This assay 
measures the ability of a toxin to prevent production of the next generation of animals.  
 
3.1.3 Lethality assay 
L4 C.elegans were exposed to various concentrations of a toxin over 3 days. After 3 days 
the worms were scored as dead or alive based on movement to determine the percent 
viability and at what concentration the toxin caused lethality. This is a standard 
toxicological assay which allows for determining the concentration at which 50% of the 
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animals are killed (LC50). Due to ease of scoring worms as dead or alive, a large sample 
can be analyzed. 
 
3.2 Optimisation of C.elegans toxicity assays 
For all three assays, initial results were highly variable, and the results were not reliable. 
Hence it was necessary to optimise a variety of parameters to ensure reproducible 
results. Thus, the vehicle medium, volume of bacteria, OD of bacterial culture, and total 
well volume was varied as per below with all other parameters as described in methods 
section 2.4.1 – 2.4.3, but in the absence of a toxin. 
S-basal, M9 Buffer, K-media and S-media were tested. There was no difference 
observed between them in any of the assays. 
The volume of OP50 Escherichia coli was tested between 10µl and 60µl with increments 
of 10µl. There was no difference between each volume tested. 
The OD of the OP50 Escherichia coli bacterial culture at 600nm was varied between 0.2 
and 0.8 increasing with increments of 0.1. Below 0.3 all three assays were affected. The 
brood size was significantly reduced and absent in some wells; a small percentage of 
lethality was observed in wells of the growth and lethality assays as well as a lack of 
growth seen in the L1 worms of the growth assay. At 0.4 and 0.5 only the growth and 
lethality assays were affected with no affect observed in the brood size assay. Above 0.5 
the assays were not affected. 
The total well volume was tested between 200µl and 600µl with increments of 100µl. 
There was no difference observed between all volumes tested. 
It was found that evaporation of water was a potentially important variable, (personal 
communication; David. R. Bell, University of Nottingham) and it was important to 
control this. 
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It was noted that after the assay plates were sealed with two layers of laboratory film, 
wrapped in a damp paper towel and enclosed in an air tight plastic container for 
incubation, results were more consistent. The damp paper towel provided humidity while 
the air tight plastic container reduced evaporation. 
The egg isolation results were initially variable and conditions for isolation of eggs were 
optimised. A protocol was established which yielded robust and reliable isolation of 
viable L1 larvae. 
 
3.3 Sodium azide positive control 
 
Sodium azide was recommended as a toxin to use as a positive control for the C.elegans 
toxicity due to its well known toxic effects. Sodium azide is a highly toxic compound 
having chemical properties and biological effects in common with cyanide (Smith 1991). 
Sodium azide inhibits cytochrome oxidase, by binding irreversibly to the heme cofactor, 
and thereby inhibiting respiration.  
 
                                 
 
3.3 Chemical structure of Sodium azide  taken from www.wikipedia.org 
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A positive control assay was set up with sodium azide along side all the toxicity assays. 
Sodium azide has been successful as a positive control, with consistent results observed 
each time for all assays.  
The IC50 values of the L1 growth sodium azide controls for the 5 toxins were, 
0.000989mM (95% CI = 0.000514 to 0.00764), 0.00160mM (95% = 0.000730 to 
0.00350), 0.00318mM (95% CI = 0.00113 to 0.00895), 0.00214mM (95% CI = 0.000863 
to 0.00512), and 0.00486mM (95% 0.00202 to 0.0116).  
 
The IC50 of the brood size sodium azide control for the 5 toxins were 0.000129mM (95% 
CI = 0.0000752 to 0.000223), 0.000175mM (95% CI = 0.0000832 to 0.000369), 
0.000147mM (95% CI = 0.0000794 to 0.000274), 0.000190mM (95% CI = 0.0000839 to 
0.000430) and 0.000167mM (95% CI = 0.0000824 to 0.000340).  
 
The IC50 values of the lethality assay sodium azide controls for the 4 toxins were 
4.34mM (95% CI = 2.90 to 7.11), 4.11mM (95% CI = 1.82 to 8.26), 4.20mM (95% CI = 
2.07 to 8.09), 4.17mM (95% CI = 1.73 to 6.21). 
There is considerable overlapping of 95% confidence intervals, seen for all the IC50 
values for all three assays, demonstrating the consistent inhibitory effect on growth, 
brood size and lethality and confirming that the assays produce reliable, consistent 
results. 
The mean IC50 value for the L1 growth sodium azide controls was 0.00255 +/-0.00152. 
The coefficient of variation is 0.6. 
The mean IC50 value for the brood size sodium azide controls was 0.000162 +/- 
0.000024. The coefficient of variation is 0.15. 
The mean IC50 value for the lethality sodium azide controls was 4.205 +/-0.0975. 
The coefficient of variation is 0.02. 
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The mean IC50 values for the three assays are significantly different showing that sodium 
azide has different potencies at particular stages of the life cycle. It shows a higher 
potency to larval and embryonic stages than adults. 
The coefficient of variation of the IC50 values for the three assays is small and shows that 
there is there is little variation, and therefore show that the assays give reproducible 
results and are a reliable measure of toxicity. 
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3.4 Quinine results 
 
    Figure 3.4.1 Effect of quinine on brood size. Individual L4 C.elegans N2 worms were 
placed in 400µl of liquid medium (s-basal) with varying concentrations of quinine or vehicle 
control (1% Ethanol) and incubated for 3 days at 15ûC, as described in section 2.4.2. After 
incubation the brood size was determined by counting the number of offspring in each well. The 
graph represents a single experiment with each concentration tested in triplicate to produce 
standard deviations (represented by the bars) and mean brood size (represented by the dots). The 
data was fitted to a non-linear regression dose response curve (log [agonist] vs. response) using 
GraphPad prism 5. This experiment was repeated giving similar results. 
 
Figure 3.4.2 Effect of sodium azide on brood size. This experiment was set up and 
analysed as in figure 3.4.1 as a positive control. 
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Figure 3.4.3 Effect of quinine on growth. 40 L1 worms per dose group were placed in 
400µl of liquid medium (s-basal) with varying concentrations of quinine or vehicle control (1% 
ethanol) and incubated for 3 days at 15ºC, as described in section 2.4.1. After incubation the 
worms were imaged with a 10X objective, using Visicapture and a Scion 1310M CCD camera, 
and the size of the worms was measured using Adobe Photoshop CS3. A minimum of 30 worms 
were measured for each concentration. The graph represents a single experiment with each 
concentration tested in triplicate to produce standard deviations (represented by the bars) and 
mean worm size (represented by the dots), where n 30. The data was fitted to a non-linear 
regression dose response curve (log [agonist] vs. response) using GraphPad Prism 5. This 
experiment was repeated with similar results. 
 
 
Figure 3.4.4 Effect of sodium azide on growth. This experiment was set up and analysed 
as in figure 3.4.3 as a positive control. 
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The effect of quinine on brood size was tested. Individual L4 animals were exposed to 
quinine at concentrations up to 3mM for 3 days. Figure 3.4.1 shows the results from this 
quinine brood size assay with the mean brood size for three replicates and standard 
deviations plot against the concentrations of quinine tested. A t-test was carried out to 
test if the difference between the treated and control values were statistically significant. 
The brood size was inhibited in a dose-dependent manner. The mean brood size was 20 
+/- 2.5 for the control (1% ethanol). The maximum inhibition was observed at 3mM. The 
IC50 was 0.568mM (95% CI = 0.347 to 0.929) 
The effect of quinine on larval growth was tested. L1 larvae were exposed to quinine at 
concentrations up to 3mM for 3 days. The animals were then photographed and 
measured using Adobe Photoshop. Figure 3.4.3 shows the results from this L1 growth 
assay with the mean size and standard deviations plot against the concentrations of 
quinine tested, for n 30. 
Growth inhibition was also affected in dose-dependent manner. The L1 C.elegans were 
0.0042mm2 +/- 0.0004 when placed in the wells. The maximum growth recorded was 
0.0123 +/- 0.0018 for the control (1% ethanol). The maximum inhibition of growth was 
observed at 3mM. The IC50 was 0.711mM (95% CI = 0.318 to 1.59). Growth was 
significantly inhibited at 0.3mM and above t = 0.086. There was no significant effect on 
growth at 0.1mM t = 0.99.  C.elegans from both the brood size and growth size assay 
remained viable at all concentrations tested. 
 It is possible that the brood size and growth size could be inhibited further with higher 
concentrations of quinine, but it was not possible to determine toxicity at concentrations 
above 3mM due to crystallisation of the quinine. An effect of lethality could not be 
determined as a concentration above 3mM is required to cause lethality. 
The sodium azide positive control results had an IC50 of 0.000989mM (95% 0.000514 to 
0.00764) and 0.000129mM (95% CI = 0.0000752 to 0.000223) for the L1 growth and 
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brood size assays respectively. These values are comparable with previous results, and 
validates that the assays are working properly and the worms are behaving as normal.  
The results show that quinine does have an effect on C.elegans, and inhibits larval 
growth and brood size.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 55
3.5 Chloroquine Results 
 
Figure 3.5.1 Effect of chloroquine on brood size. Individual L4 C.elegans N2 worms were 
placed in 400µl of liquid medium (s-basal) with varying concentrations of chloroquine or vehicle 
control (1% H2O) and incubated for 3 days at 15ûC, as described in section 2.4.2. After 
incubation the brood size was determined by counting the number of offspring in each well. The 
graph represents a single experiment with each concentration tested in triplicate to produce 
standard deviations (represented by the bars) and mean brood size (represented by the dots). The 
data was fitted to a non-linear regression dose response curve (log [agonist] vs. response) using 
GraphPad Prism. This experiment was repeated with similar results. 
 
 
Figure 3.5.2 Effect of sodium azide on brood size. This experiment was set up and 
analysed as in figure 3.5.1 as a positive control. 
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Figure 3.5.3 Effect of chloroquine on growth. 40 L1 worms per dose group were placed in 
400µl of liquid medium (s-basal) with varying concentrations of chloroquine or vehicle control 
(1% H2O) and incubated for 3 days at 15ºC, as described in section 2.4.1. After incubation the 
worms were imaged with a 10X objective, using Visicapture and a Scion 1310M CCD camera, 
and the size of the worms was measured using Adobe Photoshop CS3. A minimum of 30 worms 
were measured for each concentration. The graph represents a single experiment with each 
concentration tested in triplicate to produce standard deviations (represented by the bars) and 
mean worm size (represented by the dots), where n 30. The data was fitted to a non-linear 
regression dose response curve (log [agonist] vs. response) using GraphPad Prism 5.  
This experiment was repeated with similar results 
 
Figure 3.5.4 Effect of sodium azide on growth. This experiment was set up and analysed 
as in figure 3.5.3 as a positive control. 
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Figure 3.5.5 Effect of chloroquine on lethality. 50 L4 C.elegans N2 worms per dose group 
were placed in 400µl of liquid medium (s-basal) with varying concentrations of chloroquine or 
vehicle control (1% H2O) and incubated for 3 days at 15ûC, as described in section 2.4.3. After 
incubation the percentage of worms alive was determined by counting the number of viable and 
dead worms in each well based on movement. The graph represents a single experiment with 
each concentration tested in triplicate to produce standard deviations (represented by the bars) 
and mean percentage of viable worms (represented by the dots) where n=150. The data was fitted 
to a non linear regression dose response curve (log [agonist] vs. response) using GraphPad Prism 
5. This experiment was repeated with similar results. 
 
 
 
Figure 3.5.6 Effect of sodium azide on lethality. This assay was set up and analysed as 
described for figure 3.5.5 as a positive control. 
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The effect of chloroquine on brood size, growth and lethality of C.elegans was tested.  
Chloroquine had a dose-dependent effect on all three assays. A t-test was carried out to 
test if differences between the treated and the control values were statistically significant. 
Individual L4 animals were exposed to concentrations of chloroquine up to 15mM for 3 
days. Figure 3.5.1 shows the results from this chloroquine brood size assay, with the 
mean brood size of three replicates and standard deviations plot against the 
concentrations of chloroquine tested. There was an inhibitory effect on brood size 
observed with increasing concentrations of chloroquine. Inhibition was greatest at 
15mM, the highest concentration tested. The mean brood size for the control (1% H2O) 
was 21 +/- 1.414. The IC50 was 8.39mM (95% CI = 6.64 to 10.6). At 0.1mM, 0.3mM 
and 1mM there was no significant effect on brood size compared to the control; t = 0.4, t 
 size and standard deviations plot against the 
O) was 0.0124mm2 +/- 0.0004. The IC50 was 0.162mM (95% CI = 
= 0.47 and t = 0.6 respectively.  
L1 larvae were exposed to concentrations of chloroquine up to 15mM. After 3 days, they 
were photographed and measured using Adobe Photoshop. Figure 3.5.3 shows the results 
from this L1 growth assays with the mean
concentrations of quinine tested for n30. 
Chloroquine had an inhibitory effect on growth, of L1 C.elegans. The C.elegans had a 
mean size of 0.004mm2 +/- 0.0025 when they were placed in the wells. The greatest 
inhibition was observed at 15mM, where the mean size was 0.0041mm2 +/- 0.0007; there 
was no significant difference from the start size; t = 0.0357.  The mean size recorded for 
the control (1%H2
0.0834 to 0.316).  
L4 C.elegans were exposed to concentrations of chloroquine up to 15mM. After 3 days 
the worms were scored as dead or alive based on movement and the % alive was 
determined. Figure 3.5.5 shows the results from this lethality assay with the mean % 
viability of three replicates and standard deviations plot against the concentrations of 
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chloroquine tested. Chloroquine did have an effect on the lethal dose assay but 100% kill 
was not achieved for the concentrations tested. The maximum effect on lethality was 
observed at 15mM where the % alive was 45.39 +/- 4.73. The IC50 was 10.45mM (95% 
CI = 6.58 to 16.6). It was not possible to test above 15mM of chloroquine, as the 
 validates that the assays are working properly and the worms 
e does have an effect on C.elegans and inhibits larval 
rowth brood size and lethality. 
 
compound was not soluble above this concentration. 
The sodium azide positive control results had an IC50 of 0.00160mM (95% 0.000730 to 
0.00350), 0.000175 (95% CI = 0.0000832 to 0.000369) and 4.34 (2.90 to 7.11) for the 
L1 growth, brood size, and lethality assays respectively. These values are comparable 
with previous results, and
are behaving as normal.  
The results show that chloroquin
g
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3.6 Furan Results 
 
Figure 3.6.1 Effect of furan on brood size. Individual L4 C.elegans N2 worms were placed 
in 400µl of liquid medium (s-basal) with varying concentrations of furan or vehicle control (1% 
Ethanol) and incubated for 3 days at 15ûC, as described in section 2.4.2.After incubation the 
brood size was determined by counting the number of offspring in each well. The graph 
represents a single experiment with each concentration tested in triplicate to produce standard 
deviations (represented by the bars) and mean brood size (represented by the dots). The data was 
fitted to a non-linear regression dose response curve (log [agonist] vs. response) using GraphPad 
prism 5. This experiment was repeated giving similar results. 
 
Figure 3.6.2 Effect of sodium azide on brood size. This experiment was set up and 
analysed as in figure 3.6.1 as a positive control. 
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Figure 3.6.3 Effect of furan on growth. 40 L1 worms per dose group were placed in 400µl 
of liquid medium (s-basal) with varying concentrations of furan or vehicle control (1% ethanol) 
and incubated for 3 days at 15ºC, as described in section 2.4.1. After incubation the worms were 
imaged with a 10X objective, using Visicapture and a Scion 1310M CCD camera, and the size of 
the worms was measured using Adobe Photoshop CS3. A minimum of 30 worms were measured 
for each concentration. The graph represents a single experiment with each concentration tested 
in triplicate to produce standard deviations (represented by the bars) and mean worm size 
(represented by the dots), where n 30. The data was fitted to a non-linear regression dose 
response curve (log [agonist] vs. response) using GraphPad Prism 5. This experiment was 
repeated with similar results. 
 
 
Figure 3.6.4 Effect of sodium azide on growth size. This experiment was set up and 
analysed as in figure 3.6.3 as a positive control 
 
 62
 
Figure 3.6.5 Effect of furan on lethality. 50 L4 C.elegans N2 worms per dose group were 
placed in 400µl of liquid medium (s-basal) with varying concentrations of furan or vehicle 
control (1% ethanol) and incubated for 3 days at 15ûC, as described in 2.4.3. After incubation the 
percentage of worms alive was determined by counting the number of viable and dead worms in 
each well based on movement. The graph represents a single experiment with each concentration 
tested in triplicate to produce standard deviations (represented by the bars) and mean percentage 
of viable worms (represented by the dots) where n=150. The data was fitted to a non linear 
regression dose response curve (log [agonist] vs. response) using GraphPad Prism 5. This 
experiment was repeated with similar results. 
 
 
Figure 3.6.6 Effect of sodium azide on lethality. This assay was set up and analysed as 
described for figure 3.6.5 as a positive control. 
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The effect of furan on larval growth, brood size and lethality was tested. Furan had a 
dose-dependent effect on the brood size, growth and lethality of C.elegans. A t-test was 
carried out to test if differences between the treated and the control values were 
statistically significant. 
Individual L4 animals were exposed to concentrations of furan up to 3mM for 3 days 
and the brood size was scored. Figure 3.6.1 shows the results from this brood size assays 
with the mean brood size of three replicates and standard deviations plot against the 
concentrations of furan tested. 
The brood size of C.elegans was greatly inhibited by increasing levels of furan. The 
mean brood size recorded for the control (1% ethanol) was 19.6 +/- 1.15. The brood size 
was inhibited by 100% at 1mM and above. The IC50 was 0.102mM (95% CI = 0.0454 to 
0.231). The C.elegans remained viable at all the concentrations tested but those exposed 
to 3mM and 1mM exhibited very little movement.  
L1 C.elegans were exposed to concentrations of furan up to 3mM. After 3 days the 
worms were photographed and measured using Adobe Photoshop. Figure 3.6.3 shows 
the results from this L1 growth assay with the mean size and standard deviations plot 
against the concentrations of furan tested for n30. 
Furan had an inhibitory effect on the growth of L1 C.elegans. The L1 C.elegans were 
0.0041mm2 +/- 0.0003 when placed in the wells. The mean size was 0.0132mm2 +/- 
0.002 for the control (1% ethanol). The maximum inhibition of growth was observed at 
3mM where the mean size was 0.0063mm2 +/- 0.001. The IC50 was 0.407mM (95% CI = 
0.370 to 0.447). At 0.1mM there was no significant effect on growth, compared to the 
control size; t = 0.33. The C.elegans remained viable at all the concentrations tested.  
L4 animals were exposed to concentrations of furan up to 3mM. After 3 days the worms 
were scored as dead or alive based on movement to determine the % viability. Figure 
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3.6.5 shows the results from this lethality assay with the mean % viability of three 
replicates and standard deviations plot against the concentrations of furan tested. 
Furan had an inhibitory effect on lethality although a 100% kill was not achieved with 
the concentrations tested. The maximum effect was observed at 3mM where the % 
viable was 67.8 +/- 6.86.  At 0.1mM there is no significant effect on lethality compared 
to the control value; t = 0.58. The IC50 was 6.74mM (95% CI = 4.95 to 9.17) It was not 
possible to test concentrations above 3mM without the concentration of ethanol having a 
significant effect on the results. 
The sodium azide positive control results had an IC50 of 0.00318mM (95% 0.00113 to 
0.00895), 0.000147 (95% CI = 0.0000794 to 0.000274) and 4.11 (1.82 to 8.26) for the 
L1 growth, brood size, and lethality assays respectively. These values are comparable 
with previous results, and validates that the assays are working properly and the worms 
are behaving as normal.  
 The results show that furan does have effect on C.elegans and inhibits larval growth, 
brood size and lethality. 
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3.7 DDT Results 
 
Figure 3.7.1 Effect of DDT on brood size. Individual L4 C.elegans N2 worms were placed 
in 400µl of liquid medium (s-basal) with varying concentrations of DDT or vehicle control (0.1% 
DMSO) and incubated for 3 days at 15ûC, as described in section 2.4.2.After incubation the 
brood size was determined by counting the number of offspring in each well. The graph 
represents a single experiment with each concentration tested in triplicate to produce standard 
deviations (represented by the bars) and mean brood size (represented by the dots). The data was 
fitted to a non-linear regression dose response curve (log [agonist] vs. response) using GraphPad 
prism 5. This experiment was repeated giving similar results. 
 
Figure 3.7.2 Effect of sodium azide on brood size. This experiment was set up and 
analysed as in figure 3.7.1 as a positive control 
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Figure 3.7.3 Effect of DDT on growth. 40 L1 worms per dose group were placed in 400µl 
of liquid medium (s-basal) with varying concentrations of DDT or vehicle control (0.1% DMSO) 
and incubated for 3 days at 15ºC, as described in section 2.4.1. After incubation the worms were 
imaged with a 10X objective, using Visicapture and a Scion 1310M CCD camera, and the size of 
the worms was measured using Adobe Photoshop CS3. A minimum of 30 worms were measured 
for each concentration. The graph represents a single experiment with each concentration tested 
in triplicate to produce standard deviations (represented by the bars) and mean worm size 
(represented by the dots), where n 30. The data was fitted to a non-linear regression dose 
response curve (log [agonist] vs. response) using GraphPad Prism 5. This experiment was 
repeated with similar results. 
 
 
1% H2O 
Figure 3.7.4 Effect of sodium azide on growth. This experiment was set up and analysed 
as in figure 3.7.3 as a positive control. 
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Figure 3.7.5 Effect of DDT on lethality. 50 L4 C.elegans N2 worms per dose group were 
placed in 400µl of liquid medium (s-basal) with varying concentrations of DDT or vehicle 
control (0.1% DMSO) and incubated for 3 days at 15ûC, as described in section 2.4.3.After 
incubation the percentage of worms alive was determined by counting the number of viable and 
dead worms in each well based on movement. The graph represents a single experiment with 
each concentration tested in triplicate to produce standard deviations (represented by the bars) 
and mean percentage of viable worms (represented by the dots) where n=150. The data was fitted 
to a non linear regression dose response curve (log [agonist] vs. response) using GraphPad Prism 
5. This experiment was repeated with similar results. 
 
 
Figure 3.7.6. Effect of sodium azide on lethality. This assay was set up and analysed as 
described for figure 3.7.5 as a positive control. 
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The effect of DDT on larval growth, brood size and lethality was tested. 
 
DDT had a dose-dependent inhibitory effect on the brood size, growth and lethality of 
C.elegans. A t-test was carried out to test if differences between the treated and the 
control values were statistically significant. 
Individual L4 C.elegans were exposed to concentrations of DDT up to 0.00282mM. 
After 3 days the brood size was scored. Figure 3.7.1 shows the results from this assay 
with the mean brood size of three replicates and standard deviations plot against the 
concentrations of DDT tested. 
There was an inhibitory effect was seen in the brood size assay. The brood size was 
inhibited by 100%, at 0.00282mM DDT. The mean brood size recorded was 19.8 +/- 
1.64 for the control (0.1% DMSO). The IC50 was 0.0000946mM (95% CI = 0.0000160 
to 0.000559). All the worms remained viable for all the concentrations tested.  
L1 larvae were exposed to concentrations of DDT up to 0.00282mM. After 3 days the 
worms were photographed and measured using Adobe Photoshop. Figure 3.7.3 shows 
the results from this L1 growth assays with the mean growth and standard deviations plot 
against the concentrations of DDT tested for n30. 
A significant inhibitory effect was observed in the L1 growth assay. The worms were 
0.0041mm2 +/- 0.0001 when they were placed in the wells. The mean size recorded was 
0.0129mm2 +/- 0.00086 for the control (0.1% DMSO). The maximum inhibition of 
growth was observed at 0.00282mM DDT where the growth size recorded was 
0.0041mm2, +/- 0.0604, therefore there was no growth at all since the worms were 
placed in the wells; t = 0.002. The IC50 was 0.000000843mM (95% CI = 0.000000162 to 
0.00000439). There was very little growth with all the concentrations tested, with only a 
0.0018mm2 increase in size between the highest and lowest concentrations of DDT 
tested, therefore the range of concentrations tested was too high.  All the worms 
remained viable for the concentrations tested.  
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L4 animals were exposed to concentrations of DDT up to 0.00282mM. After 3 days the 
worms were scored as dead or alive based on movement to determine the % viability. 
Figure 3.7.5 shows the results from this lethality assay with the mean % viability of 3 
replicates and standard deviations plot against the concentrations of DDT tested. 
DDT had a significant effect on lethality, but 100% kill was not achieved with the 
concentrations tested. The greatest inhibitory effect observed was at 0.00282mM DDT, 
where viability was only 56.6% +/- 6.29. At 0.00000282mM and 0.0000282mM there was 
no significant effect on the lethality of worms compared to the control; t= 1.99 and 
t=2.00 respectively. The IC50 was 0.00338mM (95% CI = 0.00173 to 0.00658).  
The sodium azide positive control results had an IC50 of 0.00214mM (95% 0.000863 to 
0.00512), 0.000190 (95% CI = 0.0000839 to 0.000430) and 4.20 (2.07 to 8.09) for the 
L1 growth, brood size, and lethality assays respectively. These values are comparable 
with previous results, and validates that the assays are working properly and the worms 
are behaving as normal.  
The results show that DDT does have an effect on C.elegans and inhibits larval growth, 
brood size and lethality. 
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3.8 Deltamethrin Results 
 
 
 
Figure 3.8.1 Effect of deltamethrin on brood size. Individual L4 C.elegans N2 worms 
were placed in 400µl of liquid medium (s-basal) with varying concentrations of deltamethrin or 
vehicle control (0.1% DMSO) and incubated for 3 days at 15ûC, as described in section 2.4.2. 
After incubation the brood size was determined by counting the number of offspring in each well. 
The graph represents a single experiment with each concentration tested in triplicate to produce 
standard deviations (represented by the bars) and mean brood size (represented by the dots). The 
data was fitted to a non-linear regression dose response curve (log [agonist] vs. response) using 
GraphPad prism 5. This experiment was repeated giving similar results. 
 
 
Figure 3.8.2 Effect of sodium azide on brood size. This experiment was set up and 
analysed as in figure 3.8.1 as a positive control 
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Figure 3.8.3 Effect of deltamethrin on growth. 40 L1 worms per dose group were placed 
in 400µl of liquid medium (s-basal) with varying concentrations of deltamethrin or vehicle 
control (0.1% DMSO) and incubated for 3 days at 15ºC, as described in section 2.4.1. After 
incubation the worms were imaged with a 10X objective, using Visicapture and a Scion 1310M 
CCD camera, and the size of the worms was measured using Adobe Photoshop CS3. A minimum 
of 30 worms were measured for each concentration. The graph represents a single experiment 
with each concentration tested in triplicate to produce standard deviations (represented by the 
bars) and mean worm size (represented by the dots), where n 30. The data was fitted to a non-
linear regression dose response curve (log [agonist] vs. response) using GraphPad Prism 5. This 
experiment was repeated with similar results. 
 
 
Figure 3.8.4 Effect of sodium azide on growth. This experiment was set up and 
analysed as in figure 3.8.3 as a positive control. 
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Figure 3.8.5 Effect of deltamethrin on lethality. 50 L4 C.elegans N2 worms per dose 
group were placed in 400µl of liquid medium (s-basal) with varying concentrations of 
deltamethrin or vehicle control (0.1% DMSO) and incubated for 3 days at 15ûC, as described in 
section 2.4.3.After incubation the percentage of worms alive was determined by counting the 
number of viable and dead worms in each well based on movement. The graph represents a 
single experiment with each concentration tested in triplicate to produce standard deviations 
(represented by the bars) and mean percentage of viable worms (represented by the dots) where 
n=150. The data was fitted to a non linear regression dose response curve (log [agonist] vs. 
response) using GraphPad Prism 5. This experiment was repeated with similar results. 
 
Figure 3.8.6 Effect of sodium azide on lethality. This assay was set up and analysed as 
described for figure 3.8.5 as a positive control. 
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Deltamethrin had a dose-dependent effect on lethality and brood size of C.elegans; 
however the effects were only slight. A t-test was carried out to test if differences 
between the treated and the control values were statistically significant. 
Individual L4 C.elegans were exposed to concentrations of deltamethrin up to 
0.00198mM. The brood size was scored after 3 days. Figure 3.8.1 shows the results from 
this brood size assay with the mean brood size of three replicates and standard deviations 
plot against the concentrations of deltamethrin tested. 
The maximum brood size recorded was 19.6 +/- 2 for the control (0.1% DMSO). The 
greatest inhibition of brood size was at 0.00198mM deltamethrin where the mean brood 
size recorded was 10.25 +/-2.36. There was no significant difference in brood size seen 
for the concentrations of deltamethrin tested with only an increase of 3.75 between the 
highest and lowest concentrations tested t = 2.02. All the worms remained viable for all 
the concentrations tested. The IC50 was 0.00195mM (95% CI = 0.0000289 to 0.131). 
There is difficulty interpreting this experiment as there is no obvious dose-response 
effect. 
L1 larvae were exposed to concentrations of deltamethrin up to 0.00198mM. After 3 
days the worms were photographed and measured using Adobe Photoshop. Figure 3.8.3 
shows the results from the L1 growth assay with the mean size and standard deviations 
plot against the concentrations of deltamethrin tested for n30. 
Deltamethrin had a significant inhibitory effect on the growth of C.elegans. The 
C.elegans had a mean size of 0.0042mm2 +/- 0.0004, when they were placed in the wells. 
The maximum size recorded was 0.012mm2 +/- 0.0004 for the control (0.1% DMSO). 
The maximum inhibition of growth was recorded at 0.00198mM, 0.000198mM, 
0.0000198 and 0.00000198 where the mean size recorded was 0.0046 mm2 +/- 0.000292, 
0.00468 mm2 +/- 0.000366, 0.0047 mm2 +/- 0.000367, and 0.00474 mm2 +/- 0.000337, 
respectively. There was no significant difference between the measurements for all the 
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concentrations tested; t = 1.01. There was no significant difference between the start 
measurement and maximum measurement recorded for exposure to deltamethrin t = 
2.22, with only 0.0002mm2 between the two measurements, indicating very early arrest 
of development. All the worms remained viable for all the concentrations tested. The 
IC50 was 0.00000504mM (95% CI = 0.00000180 to 0.0000141). 
L4 animals were exposed to concentrations of deltamethrin up to 0.00198mM. After 3 
days the worms were scored as dead or alive based on movement to determine the % 
viability. Figure 3.8.5 shows the results from this lethality assay with the mean % 
viability of 3 replicates and standard deviations plot against the concentrations of 
deltamethrin tested. 
Deltamethrin had a slight effect on the lethality of C.elegans, but 100% was not achieved 
for the concentrations tested. The maximum effect was seen at 0.00198mM deltamethrin 
where the percentage viable was 92% +/- 2.21. There was no significant effect on 
lethality between the control and highest concentration of deltamethrin tested with less 
than a 6% difference in viability; t = 3.54. There was also no significant effect on 
lethality between the concentrations of deltamethrin tested with less than a 5% difference 
between the highest and lowest concentrations tested t =2.88. The IC50 was 0.0220mM 
(95% CI = 0.00777 to 0.0621). 
The sodium azide positive control results had an IC50 of 0.00486mM (95% 0.00202 to 
0.0116), 0.000167mM (95% CI = 0.0000824 to 0.000340) and 4.17mM (95% CI = 1.73 
to 6.21) for the L1 growth, brood size, and lethality assays respectively. These values are 
comparable with previous results, and validates that the assays are working properly and 
the worms are behaving as normal.  
The results show that deltamethrin does have an effect on C.elegans and inhibits larval 
growth and brood size. 
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3.9 Vehicle control assays 
The vehicles used in this study were ethanol as a solvent for quinine and furan, and 
DMSO as a solvent for DDT and deltamethrin. Acetone was also tested as a vehicle but 
was not used as solvent in the assays. These vehicles were tested at various 
concentrations. The concentration that had no significant effect on the C.elegans was 
used in the toxicity assays. DMSO and Acetone was tested at 0.1%, 0.5% and 1%. 
Ethanol was tested at 10%, 6%, 5%, 4%, 3%, 2% and 1%. These were tested along side 
100% S-basal as a negative control. 
 
3.9.1 DMSO as a vehicle/solvent. 
 
 
Figure 3.9.1 DMSO vehicle control for growth assay. 40 L1 worms per dose group were 
placed in 400µl of liquid medium (s-basal) with varying concentrations of DMSO or vehicle 
control (100% S-Basal) and incubated for 3 days at 15ºC, as described in section 2.4.1. After 
incubation the worms were imaged with a 10X objective, using Visicapture and a Scion 1310M 
CCD camera, and the size of the worms was measured using Adobe Photoshop CS3. A minimum 
of 30 worms were measured for each concentration. The graph represents a single experiment 
with each concentration tested in triplicate to produce standard deviations (represented by the 
bars) and mean worm size (represented by the dots), where n 30. The data was fitted to a non-
linear regression dose response curve (log [agonist] vs. response) using GraphPad Prism 5. This 
experiment was done as a vehicle control to determine if the C.elegans could handle this solvent 
and if it had an effect on growth. 
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Figure 3.9.2 DMSO vehicle control for brood size assay. Individual L4 C.elegans N2 
worms were placed in 400µl of liquid medium (s-basal) with varying concentrations of DMSO or 
vehicle control (100% s-basal) and incubated for 3 days at 15ûC, as described in section 2.4.2. 
After incubation the brood size was determined by counting the number of offspring in each well. 
The graph represents a single experiment with each concentration tested in triplicate to produce 
standard deviations (represented by the bars) and mean brood size (represented by the dots). The 
data was fitted to a non-linear regression dose response curve (log [agonist] vs. response) using 
GraphPad prism 5. This experiment was repeated giving similar results. 
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 Figure 3.9.3 DMSO vehicle control for lethality assay. 50 L4 C.elegans N2 worms per 
dose group were placed in 400µl of liquid medium (s-basal) with varying concentrations of 
DMSO or vehicle control (100%) and incubated for 3 days at 15ûC, as described in section 2.4.3. 
After incubation the percentage of worms alive was determined by counting the number of viable 
and dead worms in each well based on movement. The graph represents a single experiment with 
each concentration tested in triplicate to produce standard deviations (represented by the bars) 
and mean percentage of viable worms (represented by the dots) where n=150. The data was fitted 
to a non linear regression dose response curve (log [agonist] vs. response) using GraphPad Prism 
5. This experiment was repeated with similar results. 
 
The effect of DMSO on brood size, growth and lethality was tested as a vehicle control. 
There was a dose-dependent effect seen across all three assays. A t-test was carried out 
to test if differences between the treated and the control values were statistically 
significant. 
DMSO had a significant inhibitory effect on the brood size of C.elegans. The greatest 
inhibition was at 1% where the mean brood size was 10 +/- 1.14. There no significant 
effect on the brood size at 0.1% compared to the brood size; t =0.29. The IC50 was 
1.113% (95% CI = 0.7759 to 1.597). 
Of all the assays, the greatest inhibitory effect was seen for the L1 growth assay. The 
worms were 0.0042mm2 +/- 0.00003 when they were placed in the wells, and the 
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maximum growth recorded was 0.0115mm2 +/- 0.00097 for the control (100% S-basal). 
The greatest inhibition of growth was seen in L1 C.elegans exposed to 1% DMSO, 
where the mean size was 0.0044mm2 +/- 0.00006. There was no significant growth at 
this concentration; t =0.55, indicating very early cessation of growth. There was no 
significant difference between the control and lowest concentration of DMSO tested; t 
=1.15, with only a 0.0005mm2 difference between the measurements recorded. The IC50 
was 1.33% (95% CI = 0.0577 to 1.47) 
 DMSO showed only a slight effect on the lethality of C.elegans with only an 18% kill at 
the highest concentration tested (1% DMSO). There is no significant effect on lethality 
of C.elegans at 0.1% DMSO t =0.75, with less than 0.7% difference from the control. 
The IC50 was 4.71% (95% CI = 3.68 to 6.03). 
From these results it is clear that DMSO at 0.1% has no significant effect on C.elegans, 
growth, brood size and lethality and is suitable to use as a vehicle/solvent.  
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3.9.2 Acetone as vehicle/solvent. 
 
 
 
Figure 3.9.4 Effect of Acetone on growth. 40 L1 worms per dose group were placed in 
400µl of liquid medium (s-basal) with varying concentrations of acetone or vehicle 
control (100% S-Basal) and incubated for 3 days at 15ºC, as described in section 2.4.1. 
After incubation the worms were imaged with a 10X objective, using Visicapture and a 
Scion 1310M CCD camera, and the size of the worms was measured using Adobe 
Photoshop CS3. A minimum of 30 worms were measured for each concentration. The 
graph represents a single experiment with each concentration tested in triplicate to 
produce standard deviations (represented by the bars) and mean worm size (represented 
by the dots), where n 30. The data was fitted to a non-linear regression dose response 
curve (log [agonist] vs. response) using GraphPad Prism 5. This experiment was done as 
a vehicle control to determine if the C.elegans could handle this solvent and if it had an 
effect on growth. 
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 3.9.5 Acetone vehicle control for brood size assay. Individual L4 C.elegans N2 worms 
were placed in 400µl of liquid medium (s-basal) with varying concentrations of acetone 
or vehicle control (100% s-basal) and incubated for 3 days at 15ûC, as described in 
section 2.4.2.After incubation the brood size was determined by counting the number of 
offspring in each well. The graph represents a single experiment with each concentration 
tested in triplicate to produce standard deviations (represented by the bars) and mean 
brood size (represented by the dots). The data was fitted to a non-linear regression dose 
response curve (log [agonist] vs. response) using GraphPad prism 5. This experiment 
was repeated giving similar results. 
 
The effects of acetone on C.elegans brood size and growth was tested as a vehicle 
control. Acetone showed a dose-dependent effect on the growth and brood size of 
C.elegans. A t-test was carried out to test if differences between the treated and the 
control values were statistically significant. 
Acetone had a significant inhibitory effect on the growth of L1 C.elegans. The L1 
C.elegans had mean size of 0.004mm2 +/- 0.0002 when they were placed in the wells. At 
1% acetone, the highest concentration tested, the mean size recorded was 0.0041mm2, 
+/- 0.0013, there was no significant growth; (t =0.13) since they were placed in the well 
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and suggests immediate cessation of growth. At 0.1% acetone (the lowest concentration 
tested) there was a significant inhibition of growth compared to the control size t = 3.29.  
The IC50 was 0.125% (95% CI = 0.0747 to 0.210).  
Acetone had an inhibitory effect on the brood size of C.elegans with almost a 33% 
reduction in brood size compared to the control, recorded at 1%. At 0.1% acetone, (the 
lowest concentration tested) there was a significant reduction in brood size compared the 
control t = 1.73. The IC50 was 1.71% (95% CI = 0.477 to 6.13).  All the C.elegans 
remained viable at all the concentrations tested for these two assays. 
The effect of acetone on lethality was not tested due to the results seen from these two 
assays showing a significant effect on the growth and brood size of C.elegans even at 
0.1%, it thus not as suitable as DMSO to use as a solvent. 
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3.9.3 Ethanol as a vehicle/solvent 
 
Figure 3.9.6 Ethanol vehicle control for growth assay. 40 L1 worms per dose group 
were placed in 400µl of liquid medium (s-basal) with varying concentrations of ethanol 
or vehicle control (100% S-Basal) and incubated for 3 days at 15ºC, as described in 
section 2.4.1. After incubation the worms were imaged with a 10X objective, using 
Visicapture and a Scion 1310M CCD camera, and the size of the worms was measured 
using Adobe Photoshop CS3. A minimum of 30 worms were measured for each 
concentration. The graph represents a single experiment with each concentration tested 
in triplicate to produce standard deviations (represented by the bars) and mean worm size 
(represented by the dots), where n 30. The data was fitted to a non-linear regression 
dose response curve (log [agonist] vs. response) using GraphPad Prism 5. This 
experiment was done as a vehicle control to determine if this solvent and if it had an 
effect on growth. 
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Figure 3.9.7 Ethanol vehicle control for brood assay. Individual L4 C.elegans N2 
worms were placed in 400µl of liquid medium (s-basal) with varying concentrations of 
ethanol or vehicle control (100% s-basal) and incubated for 3 days at 15ûC, as described 
in section 2.4.2.After incubation the brood size was determined by counting the number 
of offspring in each well. The graph represents a single experiment with each 
concentration tested in triplicate to produce standard deviations (represented by the bars) 
and mean brood size (represented by the dots). The data was fitted to a non-linear 
regression dose response curve (log [agonist] vs. response) using GraphPad prism 5. 
This experiment was repeated giving similar results. 
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Figure 3.9.8 Ethanol vehicle control for lethality assay. 50 L4 C.elegans N2 worms 
per dose group were placed in 400µl of liquid medium (s-basal) with varying 
concentrations of ethanol or vehicle control (100%) and incubated for 3 days at 15ûC, as 
described in section 2.4.3. After incubation the percentage of worms alive was 
determined by counting the number of viable and dead worms in each well based on 
movement. The graph represents a single experiment with each concentration tested in 
triplicate to produce standard deviations (represented by the bars) and mean percentage 
of viable worms (represented by the dots) where n=150. The data was fitted to a non 
linear regression dose response curve (log [agonist] vs. response) using GraphPad Prism 
5. This experiment was repeated with similar results. 
  
The effect of ethanol on growth, brood size and lethality of C.elegans was tested as a 
vehicle control. A dose-dependent effect was observed across all three assays. A t-test 
was carried out to test if differences between the treated and the control values were 
statistically significant. 
Ethanol has significant inhibitory effect on the growth of L1 C.elegans. The C.elegans 
had a mean size of 0.0042mm2 +/- 0.0002 when placed in the wells. The greatest 
inhibition of growth was seen at 10% ethanol (the highest concentration tested) where 
the mean size was 0.0043mm2 +/- 0.0006, there was no significant growth at this 
concentration t = 0.27, indicating very early cessation of growth. The worms at 10% and 
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6% ethanol were dead, which would explain the lack of growth at these concentrations. 
At 1% ethanol (the lowest concentration tested) the mean size recorded was 0.0116mm2, 
there is no significant effect on growth compared to the control size t = 1.15. The IC50 
was 2.31 % (95% CI = 2.16 to 2.46). 
Ethanol had a significant inhibitory effect on the brood size, with a 100% reduction in 
brood size recorded for the top three concentrations tested (10%, 6% and 5%). The 
parental hermaphrodite at 10% and 6% ethanol was dead, but was viable at 5% with very 
little movement seen. The mean brood size was 22.3mm2 +/- 0.87 for the control (100% 
s-basal). At 1% ethanol (the lowest concentration tested) the brood size recorded was 
19.0 +/- 1.28, there is no significant effect on brood size compared to the control; t = 
3.67. The IC50 was 2.18% (95% CI = 1.92 to 2.47). 
Ethanol had a significant effect on the lethality of C.elegans, with 100% kill recorded for 
the two highest concentrations tested (10% and 6%). At 1% ethanol (the lowest 
concentration tested) there was no significant effect on lethality compared to the control; 
t = 1.53. The IC50 was 3.28% (95% CI = 3.02 to 3.57) 
From the results of these assays, it can be concluded that ethanol had an effect on growth 
brood size and lethality at all the concentrations tested; however the effect seen for 
ethanol at 1% was not significant, as demonstrated by the t-test values; and is therefore a 
suitable solvent at this concentration. 
Ethanol at 1% was used as a solvent and vehicle for furan and quinine toxicity assays. 
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3.10 PCR 
In order to confirm the genotype of the offspring of the F2 to F6 generation the parental 
hermaphrodite for each generation was genotyped. Genotyping was done by setting up 
PCR reactions using Lat-1 primers and genomic DNA of the parental hermaphrodite as 
described in  section 2.6. 
3.10.1 PCR optimisation 
PCR conditions were optimised by varying the concentrations of primers and genomic 
DNA, number of cycles and annealing temperatures. PCR products were run on a 12% 
polyacrylamide gel electrophoresis to confirm amplification. The primer concentrations 
tested were 20pm and 100pm, results showed brighter bands with 100pm for lat-1 null 
PCR product. The primer concentration did not seem to affect the wild-type PCR 
product as an equally bright band was seen with 20pm and 100pm. The concentration of 
the genomic DNA was varied by carrying out worm lysis in 10µl and 30µl of lysis 
buffer. The results showed a brighter band for the wild-type PCR product for worm lysis 
in 10µl, but did not show any difference for the lat-1 PCR product. The annealing 
temperatures tested ranged between 51ºC and 66ºC increasing by 3ºC. Wild-type PCR 
products were seen at 54ºC and 57 ºC and lat-1 PCR products were seen at 54 ºC, 57 ºC 
and 60 ºC. 54 ºC annealing temperature showed clear bright bands for both lat-1 and 
wild-type PCR products. The number of cycles for the PCR was varied; 26, 30 and 35 
cycles. The results showed a bright band at 26, 30 and 35 cycles for the lat-1 PCR 
product, but only 35 cycles for the wild-type PCR product showed any band. The PCR 
protocol was adjusted to suit the above conditions and run as described in section 2.6 
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3.11 Breeding results 
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Figure 3.11.1 Acrylamide gel showing specificity of primers. Primers were designed to 
establish the presence of the lat-1 deletion; the size of the PCR fragment amplified by these 
primers is 214bp. Another set of primers were designed to confirm the presence of the wild-type 
gene; the size PCR fragment amplified by these primers is 320bp. 30µl PCR reactions were set 
up with either set of primers, C.elegans genomic DNA, and master mix, and run for 35 cycles; 
94ºC for 30 seconds, 54ºC for 30 seconds, 72ºC for 1 minute, as described in section 2.6. The 
PCR reaction was mixed with loading buffer and run alongside a positive and negative control, 
on 12% polyacrylamide gel electrophoresis at 100V for 1 hour. The gel was visualised under a 
UV trans-illuminator, and photographed using Bio Rad Gel-Doc system and the Quantity One 
software. A 100bp DNA ladder was used and sizes up to 400bp are labelled. Every next band 
represents 100bp larger from 400bp. Lane 1 has 100bp DNA ladder. Lane 2 has CB4856 
C.elegans DNA with wild-type primers. L3 has OK1465 C.elegans DNA with wild-type primers, 
a negative control for lane 2. Lane 3 has CB4856 C.elegans DNA with Lat1 primers, a negative 
control for lane 4. Lane 4 has OK1465 C.elegans DNA with Lat1 primers.  
 
The Lat-1 ok1465 C.elegans have a deletion in the lat-1 gene and primers were designed 
to establish the presence of this lat-1 deletion, which is located between the coordinates 
18185bp and 20395bp. These primers were designed to bind just outside the deletion; the 
5’primer binds at 18011-18030bp, and the 3’primer binds at 20410-20432bp. When the 
lat-1 deletion is present the PCR fragment amplified by these primers is 214bp long. The 
PCR fragment is 2421bp long in the case of the wild-type gene. Another set of primers 
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was designed for wild-type C.elegans to amplify the region of the sequence deleted in 
the lat-1 (ok1465) C.elegans. The 5’ primer binds at 18701-18720 and the 3’ primer 
binds at 19001-19020bp. The PCR fragment amplified by these primers is 320bp long. 
PCR reactions were set up with the wild-type primers and wild-type genomic DNA, and 
lat-1 (ok1465) genomic DNA as a negative control. These reactions were loaded onto 
lanes 2 and 3 of the gel. PCR reactions with these primers produced a fragment about 
310bp in size for the reaction with the wild-type genomic DNA and no fragment for the 
reaction with lat-1 (ok1465) genomic DNA, thus confirming specificity of the primers 
showing that the wild-type primers only amplify wild-type DNA. The specificity of the 
lat-1 primers was confirmed in the same way. PCR reactions were set up and loaded onto 
lanes 4 and 5 of the gel. Lane 4 was loaded with a PCR reaction set up with the lat-1 
primers and wild-type genomic DNA and lane 5 was loaded with a PCR reaction set up 
with lat-1 (ok1465) genomic DNA. A PCR fragment of about 210bp in size was 
produced by these primers in lane 5, for the reaction with lat-1 (ok1465) DNA, no 
fragment was produced for the reaction with wild-type DNA in lane 4, which confirms 
the specificity of the lat-1 primers to only amplify DNA in a lat-1 genome. 
Figure 3.11.1 confirms the specificity of the primers, with positive and negative controls 
as described above, which verifies that the PCR products were genuine; however these 
bands were not confirmed by sequencing for further verification. 
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Figure 3.11.2 Acrylamide gel showing genotype of hermaphrodite from breeding. 
Breeding was carried out between a homozygous lat-1 (-/-) hermaphrodite and a homozygous 
wild-type (+/+) CB4856 male. In order to identify the genotype of the F3 offspring the parental 
F2 hermaphrodite was genotyped. The parental hermaphrodite could be either wild-type 
homozygous or heterozygous. The hermaphrodite was added to 10µl of lysis buffer and frozen 
for 1 hour at -80ºC and then thawed and heated for 6 hours at 65ºC and 1 hour at 94ºC to isolate 
the genomic DNA. A 30µl PCR reaction was set up, run on a gel and analysed as described for 
figure 3.11.1. A 100bp DNA ladder was used and sizes up to 400bp are labelled. Every next band 
represents 100bp larger from 400bp. Lane 1 has 100bp DNA ladder. Lane 2-7 has DNA from 
different hermaphrodites in the same generation with Lat-1 primers. Lane 8 is Lat ok1465 DNA 
with Lat-1 primers and is a positive control for lanes 2-7. Lane 9 is wild-type N2 DNA with Lat-
1 primers and is a negative control for lanes 2-7. 
 
A (ok1465) homozygous lat-1 (-/-) C.elegans hermaphrodite was crossed with a 
homozygous wild-type CB4856 (+/+) C.elegans male for 6 generations. This cross 
produced only heterozygous (+/-) offspring in the F1 generation. F1 hermaphrodites 
were crossed again with a CB4856 male to produce the F2 generation. This was repeated 
until the F6 generation.  
The genotype of the offspring for the F2 to F6 generation depended on the genotype of 
the parental hermaphrodite. A homozygous hermaphrodite (+/+) only produced 
homozygous wild-type offspring, while a heterozygous hermaphrodite (+/-) produced a 
mixture of homozygous wild-type and heterozygous offspring at 1:1 ratio. The genotype 
of the offspring from each generation was determined by genotyping the parental 
hermaphrodite. The parental hermaphrodite was either heterozygous (+/-) or wild-type 
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homozygous (+/+). PCR reactions were set up with genomic DNA of the parental 
hermaphrodite and lat-1 primers. Positive and negative control reactions were set up 
with lat-1 primers and lat-1 DNA and wild-type DNA. These PCR reactions were loaded 
onto lanes 2-7 of the gel in figure 3.11.2. The positive and negative control was loaded 
onto lanes 8 and 9 respectively. PCR fragments of about 210bp is seen in lanes 2, 3 and 
5. An identical band is seen in lane 8, the lat-1 positive control. This confirms the 
genotype of the parental hermaphrodites from lanes 2, 3 and 5 as having a lat-1 
heterozygous genotype. The absence of a PCR fragment in lane 8 confirms the 
specificity and sensitivity of the lat-1 primers and also confirms that the absence of a 
PCR fragment in lanes 4, 6 and 7 is due a homozygous wild-type genotype. The results 
shown in figure 3.11.2 are for 6 parental hermaphrodites, although at least 8 were 
genotyped for each generation. We are interested in the offspring from a heterozygous 
animal where the offspring from a breed will be 50% lat-1 heterozygous and 50% wild-
type homozygous. Picking and breeding 8 hermaphrodites from each generation gives a 
1/128 chance that a heterozygous animal will be picked. 
At each generation, at least two of the hermaphrodites genotyped were heterozygous for 
the lat-1 deletion. A successful breed is confirmed by a 1:1 male to female ratio observed 
in the offspring. However in the first generation, a successful breed was also confirmed 
by observation of more viable offspring, if the breed was unsuccessful there would be 
only 3-4 viable offspring due to the high incidence of embryonic and larval lethality seen 
in ok1465 lat-1 C.elegans. For all subsequent generations a breed was deemed successful 
if there was more than 10 male C.elegans in the offspring.  
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Figure 3.11.3 Acrylamide gel showing genotype of F6 Lat C.elegans. Breeding was 
carried out between a homozygous lat-1 (ok1465) hermaphrodite C.elegans and a homozygous 
wild-type CB4856 male C.elegans. Breeding was carried out for 6 generations as described in 
section 2.6. A 100bp DNA ladder was used and sizes up to 400bp are labelled. Every next band 
represents 100bp larger from 400bp. Lane 1 has 100bp DNA ladder. Lane 2 has F6 DNA with 
wild-type primers. Lane 3 has F6 DNA with lat primers (fragment size 220) Lane 4 has Lat1 
ok1465 DNA with Lat1 primers and is a positive control. Lane 5 has wild-type DNA with Lat1 
primers and is a negative control. 
 
After 6 generations of breeding the F6 offspring were grown to L4. 15 F6 
hermaphrodites were picked and selfed on separate NGM plates for two days. The 15 
parental hermaphrodites were genotyped and analysed as described for figure 3.10.2 on 
the third day. 3 of the 15 hermaphrodites genotyped were heterozygous. The offspring 
from heterozygous animals were each transferred to an individual NGM plates and 
allowed to self for a week. 360 animals were transferred in total. These plates were 
examined to identify a lat-1 homozygous animal. Only 1 plate was found to have 
homozygous lat-1 animals, and had approximately 7 L4 animals and many unhatched 
embryos. Plates with more than 30 viable animals were discarded. To confirm the 
genotype of these C.elegans, a hermaphrodite from this plate was genotyped as described 
for figure 3.11.2. Figure 3.11.3 shows the results from this genotyping. Lane 2 shows the 
result from a PCR reaction set up with F6 DNA and wild-type primers, where there is no 
PCR fragment. Lane 3 shows the result from a PCR reaction set up with F6 DNA and 
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lat-1 primers, which shows a PCR fragment of about 210bp in size. Lane 4 shows a PCR 
fragment of identical size, for a PCR reaction set up as a positive control with lat-1 DNA 
and lat-1 primers. Lane 5 shows the result from a PCR reaction set up with wild-type 
DNA and lat-1 primers. The presence of a PCR fragment in lane 3 which is of identical 
size to the positive control, confirms the presence of the lat-1 deletion. The absence of a 
PCR fragment in lane 2 confirms that the genotype is lat-1 homozygous and not lat-1 
heterozygous which would produce a PCR fragment of 320bp with wild-type primers. 
The absence of a PCR fragment in lane 5 confirms the sensitivity and specificity of the 
lat-1 primers as well as being a negative control. Thus these results demonstrate that the 
lat-1 (ok1465) allele has been successfully bred onto the Hawaiian (CB4856) 
background through 6 generations. 
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4. Discussion 
The C.elegans has played an invaluable role in understanding a wide range of biological 
processes and  has proven itself as a model for biological studies relevant to higher 
animals in areas such as cell death, genetics, neuroscience, development and aging 
(Nguyen 1995). Therefore it is suggested that toxicological results in C.elegans are likely 
to be relevant to higher animals. In this study C.elegans are used as a model system in 
which to examine the possible mechanisms of toxicity caused in humans by the anti-
malarial drugs quinine and chloroquine, as well as toxicity caused in rodents by furan 
and investigating the pharmacology of the insecticides DDT and deltamethrin and how 
they affect invertebrates. The results from the toxicity assays for these compounds have 
identified visible phenotypes which can be screened for, to identify resistant mutants. 
Genetic screens in C.elegans allows for molecular insight into both the mechanism of 
action of a toxin and how C.elegans may respond to protect itself from the toxin. 
Identification of genes responsible for causing toxicity in C.elegans could potentially 
help identify the genes causing toxicity in higher animals if the gene is conserved. 
 
The lat-1 (ok1465) C.elegans was crossed with the CB4856 wild-type strain of C.elegans 
through 6 generations and allowed to self to produce a homozygous lat-1 C.elegans in a 
wild-type background. Because of the 97% lethality seen in this strain, it would be 
relatively easy to screen for resistant animals that produced a normal number of 
offspring. 
 
4.1 Reliability of methods and results.  
Sodium azide was used as a positive control, as it is a known toxin, and its mechanism of 
action (inhibition of the mitochondrial electron transport chain) will affect all 
developmental stages of C.elegans. Initial results were highly variable, and so it was 
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necessary to optimise conditions. The volume and OD of the bacterial culture, the total 
well volume and different types of vehicle medium were all tested to make the toxicity 
assay methods as robust as possible. Using the optimised protocol, the results from the 
sodium azide positive control assays show that the results from these assays are 
reproducible. Specifically, the coefficient of variation was less than 0.7, showing that the 
estimates of potency showed low variability.  
In order to enhance the reliability of measurements, all toxicity assays and control assays 
were repeated at least once to ensure results were consistent. When analysing brood and 
lethality assays, worms in each well were counted at least twice. Furan assays were set 
up on ice, and each of the wells was covered with laboratory film to prevent the furan 
from vaporising. However due to its volatility the final concentrations in the wells may 
not have been accurate. As a key variable, the temperature in the incubator was 
monitored using a data logger and shown to be stable. 
In order to further enhance the statistical power of analysis, the concentrations of 
chemical tested used semi-log dilutions (i.e. dilution by three-fold, as opposed to 10-
fold) for quinine, chloroquine and furan; this provides a more robust characterisation of 
the dose-response curve, and hence estimation of EC50. Deltamethrin and DDT were 
tested using 10-fold dilutions to identify the concentrations at which there is an effect; 
however even these wide concentration ranges have not yet identified the concentration 
at which DDT and deltamethrin have an onset of effect. Further characterisation of these 
compounds would use a three-fold dilution series to estimate potency of these agents.  
 
The results of the breeding were confirmed by the acrylamide gels which showed 
genotypes of both homozygous and heterozygous animals. The results seen on the 
acrylamide gels were confirmed when the subsequent generation was genotyped, as a 
mixture of homozygous and heterozygous genotypes will be seen. The PCR reactions 
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were very sensitive to contamination, and contamination was encountered on two 
occasions. An increase in the number of cycles also affected contamination with PCR 
fragments seen for negative controls at 35 cycles but not at 26 cycles; however this did 
not occur when using fresh primers. Primers were aliquot and a fresh aliquot was used 
for each set of PCR reactions set up to minimise cross contamination. It was observed 
that no contamination occurred after the PCR reactions were set up under a PCR hood 
using filter tips. 
 
8 hermaphrodites were picked at each generation for the next round of breeding; to 
increase the possibility of picking at least one heterozygous animal. The probability of 
all 8 hermaphrodites picked being homozygous is 1/256. On one occasion during 
breeding two of these hermaphrodites died when being transferred, leaving only 6 
hermaphrodites and increasing the probability to 1/64 that all the hermaphrodites would 
be homozygous wild-type. To account for such occurrences at least 12 hermaphrodites 
should have been picked at each generation, which would reduce the probability of 
picking all homozygous animals to 1/4096. It was also important that the hermaphrodites 
picked for breeding were virgins. To ensure this, only L4 hermaphrodites were selected 
for breeding. It is vital that the hermaphrodite is at the L4 stage and the vulva has not yet 
formed, in order to allow time for mating and ensure self-fertilization of the eggs does 
not occur. An L4 hermaphrodite can be recognised by a half moon shape in the middle of 
the body which is the developing vulva. 
 
4.2 Vehicles 
Ethanol, H20 and DMSO were used as vehicles in this study. Ethanol at 1% was used as 
a vehicle for Furan and Quinine, H20 was used as a vehicle for chloroquine and sodium 
azide and DMSO at 0.1% was used as a vehicle for DDT and deltamethrin. The vehicle 
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used in these assays is very important as they can have a significant effect on the 
C.elegans and affect the results of the assay. It is important that the vehicle used has no 
significant effect on the characteristic being tested, to ensure the results show a response 
that is due to the effects of the toxin and not a combined effect of the vehicle and toxin. 
Where possible H20 should be used as a vehicle, as it has no effect on C.elegans, 
however this is not always possible due to the low solubility of some compounds in 
H20.The effects Ethanol and DMSO at different concentrations were tested in all three 
assays with a negative control of 100% s-basal. 1% ethanol and 0.1% DMSO showed 
minimal or no significant effect on the characteristic being tested and was used in the 
assays as a vehicle. The results from the toxicity assays of Furan, Quinine, DDT and 
deltamethrin should be compared with the results from the vehicle control assays to 
determine the effects of the toxin from the effects of the vehicle. This comparison 
highlighted the inhibitory effects of ethanol on growth and brood size as the control 
values of growth and brood size in the quinine and furan assays (1% ethanol) was 
slightly lower than the control values recorded in the absence of ethanol (100% s-basal) 
for the ethanol vehicle control assays, however these difference were not significant. 
Ethanol at 1% had no significant effect on the lethality of C.elegans which was 
confirmed by similar control values between the ethanol vehicle control assay and furan 
lethality assay. Comparison of DDT and deltamethrin results to DMSO vehicle control 
results confirmed that DMSO at 0.1% had no effect on the growth, brood size or lethality 
of C.elegans with similar control values recorded between the DMSO vehicle control 
assays and all the DDT and deltamethrin assays. These results confirm the suitability of 
DMSO at 0.1% as vehicle for these studies in C.elegans. Due to effects of ethanol 
observed even at 1% (although not significant), DMSO should have been used instead of 
ethanol as a vehicle for furan and quinine. 
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4.3 Quinine  
The effect of quinine on C.elegans at different stages of its life cycle was tested between 
0.1mM and 3mM using toxicity assays as described in section 2.4.1-2.4.2. Quinine had a 
dose-dependent inhibitory effect on brood size and growth of C.elegans. There was no 
significant effect on brood size and larval growth at 0.1mM and quinine causes toxicity 
in C.elegans at 0.3mM and above. The IC50 for the quinine brood size assay was 
0.568mM (95% CI = 0.347 to 0.928) and 0.711mM (95% CI = 0.318 to 1.59) for the L1 
growth assay. This shows that the quinine was slightly more toxic to larval growth than 
brood size. The concentration at which quinine causes toxicity in C.elegans is 
comparable to the concentration causing toxicity in humans. 
 
4.4 Chloroquine 
The effect of chloroquine on C.elegans at different stages of its life cycle was tested 
between 0.1mM and 15mM using toxicity assays as described in section 2.4.1-2.4.3. 
Chloroquine had a dose-dependent inhibitory effect on the brood size, larval growth and 
lethality of C.elegans. There was no significant effect on brood size compared to the 
control below 1mM. The IC50 was 8.40mM (95% CI = 6.635 to 10.62). Larval growth 
was significantly inhibited at all concentrations tested. The IC50 was 0.162mM (95% CI 
= 0.0834 to 0.316). There was no significant effect on lethality of C.elegans below 
0.3mM. The IC50 was 10.45mM (95% CI = 6.58 to 16.6). The IC50 values for these three 
assays show that chloroquine was significantly more toxic to larval growth than brood 
size and lethality. The IC50 for the lethality assay is considerably higher than those for 
the growth and brood size assays and shows that there is a considerable difference in 
toxicity between these three assays. The concentration at which chloroquine causes 
toxicity in C.elegans is comparable to the concentration causing toxicity in humans. 
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4.5 Furan 
The effect of furan on C.elegans at different stages of its life cycle was tested between 
0.1mM and 3mM using toxicity assays as described in section 2.4.1-2.4.3. Furan had a 
dose-dependent inhibitory effect on the brood size, larval growth and lethality of 
C.elegans. Brood size was significantly affected at all the concentrations tested, and was 
inhibited by 100% at 1mM and above. The IC50 was 0.1023mM (95% CI = 0.0454 to 
0.231). There was no significant effect on larval growth below 0.3mM. The IC50 was 
0.407mM (95% CI = 0.370 to 0.447). There was no significant effect on the lethality of 
C.elegans below 0.3mM. The IC50 was 6.74mM (95% CI = 4.95 to 9.17). The IC50 
values show that furan was significantly more toxic to brood size than for larval growth 
and lethality. The IC50 for the lethality assay is considerably higher than those for the 
other assays and shows that the brood size and larval growth are more sensitive to the 
effects of furan. The results show that furan causes toxicity at 0.3mM and above in the 
growth and lethality assays whereas in the brood size assay toxicity occurs even at 
concentrations below 0.1mM. For comparison, furan causes hepatic toxicity in rats after 
a dose of 8 mg/ kg/ day, which would be an instantaneous concentration of ~0.1mM. The 
comparison is inexact, since this estimate takes no account of distribution/ metabolism, 
repeat dosing, or potential loss of furan by volatilisation in our study. Thus furan is 
acting as a potent toxin at doses comparable to those where it induces toxicity in rodents, 
suggesting that there may be a common mechanism of action. 
The considerably higher toxicity of furan on embryos over adult and larval stages is 
interesting and could be due to a metabolic pathway that is not yet developed in 
embryonic stages but is functional at larval and adult stages which decreases the toxicity 
of this drug at these stages. It may also be due to a receptor which is only active during 
embryogenesis. 
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4.7 DDT 
The effect of DDT on C.elegans at different stages of its life cycle was tested between 
0.00000282mM and 0.00282mM using toxicity assays as described in section 2.4.1-
2.4.3. DDT had a dose-dependent effect on brood size and lethality of C.elegans. There 
was a significant inhibitory effect on brood size at all the concentrations tested, with a 
100% reduction in brood size at 3mM.  The IC50 was 0.0000946mM (95% CI = 
0.0000160 to 0.000559). 
There was a significant inhibitory effect on larval growth compared to the control at all 
the concentrations tested. There was no significant growth at all the concentrations tested 
since the worms were placed in the wells, showing that the range of concentrations tested 
was too high. The IC50 was 0.000000843mM (95% CI = 0.000000162 to 0.00000439). 
There was no significant effect on lethality of C.elegans at 0.0000282mM and below. 
The IC50 was 0.003375mM (95% CI = 0.001732 to 0.006575). The IC50 values show that 
DDT has different considerably different toxicities at different stages and is significantly 
more potent at larval stages than on brood size and L4 C.elegans. 
 
4.8 Deltamethrin 
The effect of deltamethrin on C.elegans at different stages of its life cycle was tested 
between 0.00000198mM and 0.00198mM using toxicity assays as described in section 
2.4.1-2.4.3. There was a significant difference in brood size between the control and 
treated. However, there was no significant difference in brood size between all the 
concentrations tested. There is difficulty interpreting the results of this experiment and 
although the reduction in brood size between the control and treated is significant, I do 
not think these results show a dose-response relationship between deltamethrin and 
effect on brood size over 3 logs of concentration. This experiment was repeated giving 
similar results. The IC50 was 0.00195mM (95% CI = 0.0000290 to 0.131). There was a 
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significant inhibitory effect seen on larval growth compared to the control at all 
concentrations tested. There was no significant growth at all concentrations compared to 
the start size, and no significant difference in size between the concentrations tested. The 
concentrations of deltamethrin tested were too high to see a dose-dependent effect. The 
IC50 was 0.00000504mM (95% CI = 0.00000180 to 0.0000141). Deltamethrin had no 
significant effect on the lethality of C.elegans. There was no significant difference 
between the control and treated and significant difference between the concentrations 
tested. The IC50 was 0.0220mM (95% CI = 0.00776 to 0.0621). The IC50 values show 
that deltamethrin is significantly more potent to larval growth than brood size and L4 
C.elegans and shows stage-specific toxicity. This stage specific toxicity is interesting as 
it is not seen in other toxins. This toxicity could be due to deltamethrin binding to a 
receptor that is that is only present during larval growth. Adult C.elegans were not 
affected by deltamethrin, which may be due to the cuticle having a decreased 
permeability to the drug at the adult stage. 
 
4.8 Screening and mutagenesis. 
In order to identify genes that are responsible for drug toxicity a genetic screen needs to 
be carried out. The C.elegans would be screened for mutants that were resistant to the 
effects of the drug tested. Resistance is defined as the ability to grow and reproduce at 
concentrations that prevent wild-type animals. This would involve identifying mutants 
where either the brood size or growth size was no longer inhibited by exposure to the 
compound or where exposure no longer had a lethal effect. A simple F2 screen would 
initially identify these mutants. During an F2 screen genes in the germ cells are randomly 
mutated by exposing a population of wild-type F0 hermaphrodites to a mutagen, such as 
ethyl methane sulphonate (EMS). A particular mutation in an egg or sperm would result 
in a heterozygous F1 individual (for that mutation) when fertilization occurs (Jorgensen 
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2002). This mutation would be transmitted to the F2 generation as the F1 individual 
would produce eggs and sperm carrying this particular mutation. Self fertilisation of the 
F1 individual would result in a F2 generation where 25% of the progeny would be 
homozygous for the mutation. In order to identify if this mutation is involved in the 
mechanism of toxicity for a particular toxin, the F2 generation would have to be screened 
to identify individuals that were no longer affected by the toxin. This would be done by 
exposing the F2 generation to the toxin as described for the three assays in section     
2.4.1 – 2.4.3. If such individuals are found, they would be transferred to a fresh agar 
plate and left for 3 day to self-fertilise producing the F3 generation. In order to determine 
whether the mutant phenotype breeds true and is passed through to the next generation, 
the F3 progeny are exposed to a particular toxin to identify animals that are no longer 
affected by the toxin just as described for the F2 generation. Using this method one null 
mutation at a particular locus is recovered for every 2,000 copies of a gene analysed in a 
screen. 12,000 copies of a gene can be assayed in a typical screen of haploid genomes, 
thus we would expect to recover six mutations in a particular gene (Jorgensen 2002). 
In the case of lat-1 (ok1465) C.elegans, which as described previously were crossed with 
the CB4856 strain to generate a homozygous lat-1 strain in a wild-type background, 
mutagenesis, would be carried out in the same way however screening would be to 
identify mutant individuals that no longer showed lethality. This would be relatively 
easy as the majority of animals would only produce 2/3 viable offspring per generation 
and a resistant mutant would produce 300+ viable offspring. 
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5. Conclusion and further studies. 
In this study, toxicity assays were used to determine the effects of chloroquine, quinine, 
furan, DDT and deltamethrin on the growth and development, brood size and lethality in 
the model organism Caenorhabditis elegans. 
For each of the toxins tested, a visible phenotype was identified for all three toxicity 
assays, which can be used to screen for resistant mutants. 
It was found that quinine had a dose-dependent inhibitory effect on larval growth and 
brood size. Chloroquine, furan and DDT all had an inhibitory effect on growth, brood 
size and lethality of C.elegans. Chloroquine and DDT showed a greater potency on larval 
growth while furan showed a higher potency on brood size. Deltamethrin showed 
inhibitory effects on larval growth but showed no significant effect to the brood size and 
lethality of C.elegans. Deltamethrin showed stage-specific toxicity, as larval growth is 
significantly inhibited and effects on brood size and lethality were insignificant. 
Breeding was carried out between the Lat-1 (ok1465) strain and the Hawaiian CB4856 
strain to generate a homozygous strain carrying the lat-1 deletion in a Hawaiian 
(CB4856) background. 
 
5.1 Further Studies  
C.elegans from these toxicity assays could be monitored to determine if there are any 
visible physiological affects that can be seen which may help explain how the toxins 
tested inhibit growth and development, brood size or lethality. 
 
5.2 Genetic Mapping 
The goal of genome mapping is to generate high resolution maps of chromosomes which 
are useful for investigating genes and their functions. A mutation must be mapped to 
determine the identity of the gene (Swan 2002). 
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Since its introduction in 2001, single nucleotide polymorphism (SNP) mapping has 
transformed genetic linkage studies in C.elegans, and has made SNP the technique of 
choice for many C.elegans researchers. In SNP mapping, a genome map is constructed 
using SNPs as genetic markers; it is the easiest and most reliable way to map genes in 
C.elegans. DNA markers are molecular markers, DNA regions in the genome that differ 
sufficiently between individual strains of C.elegans so that they so that they can be 
detected by molecular analysis of DNA. Using SNPs as genetic markers for mapping is 
advantageous and favoured, due to their relative abundance and because they have no 
associated phenotype unlike conventional marker mutations used in traditional methods 
of linkage mapping of mutations which rely on the use of markers that cause a visible 
phenotype. Some mutant phenotypes such as those with subtle behavioural defects that 
would normally be masked by conventional marker mutations can be mapped using 
SNPs. Using SNP mapping it is possible to narrow down the location of a mutation to a 
region smaller than a single cosmid and theoretically to a single gene (wormbook). 
In SNP mapping DNA sequence polymorphisms between the N2 wild-type C.elegans 
strain and the closely related CB4856 C.elegans strain are used as genetic markers. The 
CB4856 C.elegans show a uniformly high density of polymorphisms in comparison to 
the N2 wild-type. On average differences in the genomic sequence of CB4856 and N2 
occur every 1000bp. Single nucleotide polymorphisms are in fact single nucleotide 
changes in the nucleotide sequence. These are normally changes from a C to T or an A to 
a G; however changes such as an insertion or deletion of a nucleotide are also common. 
A listing of the SNPs that exist between CB4856 and N2, and their genetic position on 
the chromosome is found in the SNP database. The SNP database is organised according 
to the physical map by chromosomes, chromosomal segments and cosmids (worm 
book). 
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For standard SNP mapping, the aim is to map mutations relative to SNP markers in 
CB4856. First the linkage relationship between resistance causing mutations and SNP 
markers in CB4856 must be established. To do this we must obtain a homozygous 
resistant mutant with CB4856 SNP markers. Mutant animals are generated by chemical 
mutagenesis and resistant mutants are identified by screening as described in section 4.8. 
A population of resistant mutants was generated by allowing resistant animals to self-
fertilize. CB4856 males would then crossed into a hermaphrodite resistant mutant, 
producing a heterozygous cross progeny which are left to grow and self fertilize, which 
would regenerate homozygous resistant mutants (wormbook). In the case of the 
homozygous lat-1 resistant mutants which would be identified as described in section 
2.6, these mutants would be crossed with males from the F6 generation of breeding 
rather than CB4856 males. A few animals from this F2 generation are randomly picked 
into tubes containing worm lysis buffer and lysed as described in section 2.7. PCR 
reactions are then set up using the lysate as described in section 2.6 but with primers 
designed to amplify the region of DNA containing the SNP being tested. After 
amplification the PCR products would be digested with a restriction enzyme specific to 
the SNP being tested for. These digestion reactions would then be loaded and run on an 
agarose gel. 
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 Figure 5.2 Two point SNP mapping. 
This figure shows the basic scheme for two-point SNP mapping, showing that the closer a 
mutation lies to the SNP being tested the less likely a homozygous mutant will carry an allele of 
that polymorphism. This figure shows the linkage between the homozygous mutant and an SNP 
used to position the mutant on the chromosome relative to the SNP 
 
Figure 5.2 shows a diagrammatic representation of the procedure described above, of 
two-point SNP mapping. If the mutation and the SNP being mapped and tested are on 
the same chromosome it is very unlikely that the homozygous mutant will harbour a 
CB4856 allele of that polymorphism. 
 
Mutant strains that show drug resistance are generally resistant through one of three 
mechanisms.  
x Mutations that alter the target site for the drug, rendering it dysfunctional, or less 
sensitive.  
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x Mutations that affect the metabolism of the drug or alter permeability thereby 
decreasing the concentration at which the drug is effective at the sensitive site. 
x Mutations that lead to cellular or metabolic alterations that can bypass or 
compensate for the action of the toxin (Nguyen 1995). 
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6. Appendix 
A1. Chloroquine brood assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Chloroquine (µl) 
15 40 320 40 of 150mM 
10 40 328 32 of 125mM 
3 40 352 8 of 150mM 
1 40 356 4 of 100mM 
0.3 40 356 4 of 30mM 
0.1 40 356 4 of 10mM 
0 40 356 4 of H2O 
 
A2. Chloroquine brood assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Chloroquine(µl) L1 Worms (µl) 
15 40 315 40 of 150mM 5 
10 40 323 32 of 125mM 5 
3 40 347 8 of 150mM 5 
1 40 351 4 of 100mM 5 
0.3 40 351 4 of 30mM 5 
0.1 40 351 4 of 10mM 5 
0 40 351 4 of H2O 5 
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A3. Chloroquine lethality assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Chloroquine(µl) L4 Worms (µl) 
15 40 315 40 of 150mM 5 
10 40 323 32 of 125mM 5 
3 40 347 8 of 150mM 5 
1 40 351 4 of 100mM 5 
0.3 40 351 4 of 30mM 5 
0.1 40 351 4 of 10mM 5 
0 40 351 4 of H2O 5 
 
A4. Quinine brood assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Quinine (µl) 
3 40 355.2 4.8 of 250mM 
1 40 356 4 of 100mM 
0.3 40 356 4 of 30mM 
0.1 40 356 4 of 10mM 
0 40 356 4 of ethanol 
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A5. Quinine growth assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Quinine (µl) L1 Worms (µl) 
3 40 350.2 4.8 of 250mM 5 
1 40 351 4 of 100mM 5 
0.3 40 351 4 of 30mM 5 
0.1 40 351 4 of 10mM 5 
0 40 351 4 of ethanol 5 
 
A6. Furan brood assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Furan (µl) 
3 40 352 8 of 150mM 
1 40 356 4 of 100mM 
0.3 40 356 4 of 30mM 
0.1 40 356 4 of 10mM 
0 40 356 4 of ethanol 
 
A7.  Furan growth assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Furan (µl) L1 Worms (µl) 
3 40 347 8 of 150mM 5 
1 40 351 4 of 100mM 5 
0.3 40 351 4 of 30mM 5 
0.1 40 351 4 of 10mM 5 
0 40 351 4 of ethanol 5 
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A8. Furan lethality assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Furan (µl) L4 Worms (µl) 
3 40 347 8 of 150mM 5 
1 40 351 4 of 100mM 5 
0.3 40 351 4 of 30mM 5 
0.1 40 351 4 of 10mM 5 
0 40 351 4 of ethanol 5 
 
A9. DDT brood assay. 
   % DDT  OP50 (µl) S-Basal (µl) DDT (µl) 
0.001 40 359.6 0.4 of 2.82mM 
0.0001 40 359.6 0.4 of 0.282mM 
0.00001 40 359.6 0.4of 0.0282mM 
0.000001 40 359.6 0.4of 0.00282mM 
0 40 359.6 0.4 of 0.1% DMSO 
 
A10. DDT growth assay. 
   % DDT  OP50 (µl) S-Basal (µl) DDT (µl) L1 Worms (µl) 
0.001 40 354.6 0.4 of 2.82mM 5 
0.0001 40 354.6 0.4 of 0.282mM 5 
0.00001 40 354.6 0.4of 0.0282mM 5 
0.000001 40 354.6 0.4of 0.00282mM 5 
0 40 354.6 0.4 of 0.1% DMSO 5 
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A11. DDT lethality assay. 
% DDT OP50 (µl) S-Basal (µl) DDT (µl) L4 Worms (µl) 
0.001 40 354.6 0.4 of 2.82mM 5 
0.0001 40 354.6 0.4 of 0.282mM 5 
0.00001 40 354.6 0.4of 0.0282mM 5 
0.000001 40 354.6 0.4of 0.00282mM 5 
0 40 354.6 0.4 of 0.1% DMSO 5 
 
A12 Deltamethrin brood assay. 
% Deltamethrin OP50 (µl) S-Basal (µl) Deltamethrin (µl) 
0.001 40 359.6 0.4 of 1.98mM 
0.0001 40 359.6 0.4 of 0.198mM 
0.00001 40 359.6 0.4of 0.0198mM 
0.000001 40 359.6 0.4of 0.00198mM 
0 40 359.6 0.4 of 0.1% DMSO 
 
A13. Deltamethrin growth assay. 
Deltamethrin (%) OP50 (µl) S-Basal (µl) DM (µl) L1 Worms (µl) 
0.001 40 359.6 0.4 of 1.98mM 5 
0.0001 40 359.6 0.4 of 0.198mM 5 
0.00001 40 359.6 0.4of 0.0198mM 5 
0.000001 40 359.6 0.4of 0.00198mM 5 
0 40 359.6 0.4 of 0.1%DMSO 5 
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A14. Delthamethrin lethality assay. 
Deltamethrin (%) OP50 (µl) S-Basal (µl) DM (µl) L4 Worms (µl) 
0.001 40 359.6 0.4 of 1.98mM 5 
0.0001 40 359.6 0.4 of 0.198mM 5 
0.00001 40 359.6 0.4of 0.0198mM 5 
0.000001 40 359.6 0.4of 0.00198mM 5 
0 40 359.6 0.4 of 0.1%DMSO 5 
 
A15. Control ethanol brood assay. 
Ethanol (%) OP50 (µl) S-Basal (µl) Ethanol (µl) 
10 40 320 40 
6 40 336 24 
5 40 340 20 
4 40 344 16 
3 40 348 12 
2 40 352 8 
1 40 356 4 
0 40 360 0 
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A16. Control ethanol growth assay. 
Ethanol (%) OP50(µl) S-Basal(µl) Ethanol(µl) L1 Worms(µl) 
10 40 315 40 5 
6 40 331 24 5 
5 40 335 20 5 
4 40 339 16 5 
3 40 343 12 5 
2 40 347 8 5 
1 40 351 4 5 
0 40 355 0 5 
 
A17. Control ethanol lethality assay. 
Ethanol (%) OP50(µl) S-Basal(µl) Ethanol(µl) L4 Worms(µl) 
10 40 315 40 5 
   6 40 331 24 5 
5 40 335 20 5 
4 40 339 16 5 
3 40 343 12 5 
2 40 347 8 5 
1 40 351 4 5 
0 40 355 0 5 
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A18. Control sodium azide brood assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Sodium Azide (µl) 
1 40 356 4 of 100mM 
0.1 40 356 4 of 10mM 
0.01 40 356 4 of 1mM 
0.001 40 356 4 of 0.1mM 
0.0001 40 356 4 of 0.01 
0 40 356 4 of H2O 
 
A19. Control sodium azide growth assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Sodium Azide (µl) L1 Worms (µl) 
1 40 351 4 of 100mM 5 
0.1 40 351 4 of 10mM 5 
0.01 40 351 4 of 1mM 5 
0.001 40 351 4 of 0.1mM 5 
0.0001 40 351 4 of 0.01mM 5 
0 40 351 4 of H2O 5 
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A20. Control sodium azide lethality assay. 
Concentration (mM) OP50 (µl) S-Basal (µl) Sodium Azide (µl) L4 Worms (µl) 
1 40 351 4 of 100mM 5 
0.1 40 351 4 of 10mM 5 
0.01 40 351 4 of 1mM 5 
0.001 40 351 4 of 0.1mM 5 
0.0001 40 351 4 of 0.01mM 5 
0 40 351 4 of H2O 5 
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